<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2025.1728903</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human PMNs exhibit greater engulfment, NETosis, and enhanced migration when incubated with nontypeable <italic>Haemophilus influenzae</italic> newly released from a biofilm</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wilbanks</surname> <given-names>Kathryn Q.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/3285373/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Flesher</surname> <given-names>Joshua</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/3285432/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Goodman</surname> <given-names>Steven D.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/389226/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Bakaletz</surname> <given-names>Lauren O.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/182446/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Center for Microbe and Immunity Research, Abigail Wexner Research Institute at Nationwide Children&#x2019;s Hospital</institution>, <city>Columbus, OH</city>, <country country="us">United States</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Pediatrics, The Ohio State University College of Medicine</institution>, <city>Columbus, OH</city>, <country country="us">United States</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Lauren O. Bakaletz, <email xlink:href="mailto:Lauren.Bakaletz@nationwidechildrens.org">Lauren.Bakaletz@nationwidechildrens.org</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-11-27">
<day>27</day>
<month>11</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1728903</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Wilbanks, Flesher, Goodman and Bakaletz.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wilbanks, Flesher, Goodman and Bakaletz</copyright-holder>
<license>
<ali:license_ref start_date="2025-11-27">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Biofilm-resident bacteria exhibit diverse mechanisms to evade eradication, including the highly protective self-produced matrix in which they are embedded. Thus, releasing bacteria from biofilm residence affords antibiotics and immune effectors greater access. We developed a monoclonal antibody directed against an essential biofilm matrix protein that induces rapid collapse of the biofilm matrix with release of bacteria that are in a transient but highly vulnerable phenotype. Bacteria that are newly released (&#x201C;NRel&#x201D;) due to this monoclonal are significantly more sensitive to antibiotic-, antimicrobial peptide- or human PMN-mediated killing <italic>in vitro</italic> and are rapidly eradicated in four animal models without adjunct antibiotic treatment, the speed of which highlights the role of innate immune effectors. Here, we characterized the reactivity of human PMNs to three distinct bacterial populations derived from three clinical isolates of the predominant respiratory tract pathogen nontypeable <italic>Haemophilus influenzae</italic> (NTHI). Via timelapse microscopy and flow cytometry, PMN engulfment, NETosis (e.g., programmed neutrophil cell death accompanied by release of web-like condensed DNA with associated antimicrobial proteins), and migratory activity were assessed when PMNs were incubated with NTHI that were dual-fluorescently labeled with green-fluorescent FM 1&#x2013;43 and pH-sensitive red-fluorescent pHrodo&#x2122; Red, SE, which fluoresces in acidic environments such as within a phagolysosome. Relative concentrations of endotoxin and DNA, as well as cytokines/chemokines potentially responsible for observed PMN activities were also assessed. PMN-mediated engulfment, NETosis, and migratory activity were all greatest when incubated with NTHI NRel compared to both NTHI that had been grown planktonically in rich medium or to NTHI that were present in the culture medium that overlayed the biofilm. Whereas neither NTHI endotoxin nor DNA played a role in the observed relative activities, PMNs incubated with NTHI NRel released significantly more IL-8 which likely served to enhance the migration of additional PMNs. These data contribute to our understanding of mechanisms anticipated to be operational in the DNABII protein-targeted monoclonal antibody-based treatment regimen we developed to facilitate host-mediated contribution to biofilm eradication after induced release of formerly biofilm-resident bacteria into the highly vulnerable NRel state.</p>
</abstract>
<kwd-group>
<kwd>DNABII</kwd>
<kwd>NRel</kwd>
<kwd>freshly dispersed</kwd>
<kwd>LOS</kwd>
<kwd>DNA</kwd>
<kwd>IL-8</kwd>
<kwd>timelapse microscopy</kwd>
<kwd>flow cytometry</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>National Institute on Deafness and Other Communication Disorders</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100000055</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by NIH/NIDCD R01 DC003915 to LB.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="68"/>
<page-count count="14"/>
<word-count count="11035"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Agents and Disease</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Bacterial biofilms are implicated in a substantial proportion of bacterial infections, particularly those that are chronic, recurrent, recalcitrant to treatment or device-related (<xref ref-type="bibr" rid="B13">Di Domenico et al., 2022</xref>). Importantly, biofilm-resident bacteria are significantly more tolerant to antibiotics and effectors of the host immune system (<xref ref-type="bibr" rid="B40">Mirghani et al., 2022</xref>; <xref ref-type="bibr" rid="B66">Yang et al., 2023</xref>). In fact, bacteria within biofilms are 10 to 1,000-fold less susceptible to antimicrobial agents than their isogenic planktonically growing counterparts, which often ultimately leads to ineffective medical management, prolonged disease course, delays in time to healing, or even the need for invasive interventions to attempt infection resolution (<xref ref-type="bibr" rid="B64">Uru&#x00E9;n et al., 2020</xref>).</p>
<p>To more effectively resolve biofilm-related diseases, development of novel approaches are of great priority and urgency and many laboratories are working toward such goals (<xref ref-type="bibr" rid="B59">Shrestha et al., 2022</xref>). In our lab, we&#x2019;ve been focused on the ubiquitous DNABII family of bacterial DNA-binding and -bending proteins that function as architectural elements both inside and outside the bacterial cell. The two DNABII proteins, histone-like protein (HU) and integration host factor (IHF), lend essential structural support to the lattice-like network of extracellular DNA (eDNA) in the biofilm matrix as they are positioned at the vertices of crossed strands of eDNA and thereby serve as linchpin proteins that bind to, bend, and stabilize double-stranded eDNA (<xref ref-type="bibr" rid="B62">Swinger and Rice, 2004</xref>; <xref ref-type="bibr" rid="B12">Dey et al., 2017</xref>; <xref ref-type="bibr" rid="B11">Devaraj et al., 2018</xref>). As DNABII proteins are essential components of the biofilm matrix, we developed a monoclonal antibody (mAb) directed against a synthetic &#x201C;tip-chimer&#x201D; peptide immunogen designed to mimic the immunoprotective DNA-binding &#x201C;tips&#x201D; of a DNABII protein as determined by epitope mapping studies (<xref ref-type="bibr" rid="B18">Goodman et al., 2011</xref>; <xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B47">2019</xref>). When biofilms formed <italic>in vitro</italic> by a diverse array of human pathogens are incubated with this mAb (&#x201C;&#x03B1;-DNABII&#x201D;), an equilibrium shift occurs wherein free DNABII proteins that have come off of the biofilm matrix are then bound by the mAb which prevents their ability to rebind to the eDNA within the biofilm matrix. As a result, the structural lattice is destabilized which leads to significant biofilm collapse with concomitant rapid release of formerly biofilm-resident bacteria (<xref ref-type="bibr" rid="B24">Jurcisek et al., 2022</xref>; <xref ref-type="bibr" rid="B30">Kurbatfinski et al., 2022</xref>, <xref ref-type="bibr" rid="B31">Kurbatfinski et al., 2023a</xref>; <xref ref-type="bibr" rid="B52">Rhodes et al., 2024</xref>).</p>
<p>Regardless of the method or agent used, many laboratories report that bacteria which have recently exited or been forced out of biofilm residence exhibit a transient, yet distinct, phenotype that often includes significantly increased susceptibility to antibiotic-mediated killing relative to planktonically grown counterparts (<xref ref-type="bibr" rid="B37">Marks et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Li et al., 2014</xref>; <xref ref-type="bibr" rid="B50">Petrova and Sauer, 2016</xref>; <xref ref-type="bibr" rid="B7">Chambers et al., 2017</xref>; <xref ref-type="bibr" rid="B19">Goodwine et al., 2019</xref>; <xref ref-type="bibr" rid="B56">Rumbaugh and Sauer, 2020</xref>; <xref ref-type="bibr" rid="B67">Zemke et al., 2020</xref>; <xref ref-type="bibr" rid="B26">Kalia and Sauer, 2024</xref>). This enhanced sensitivity characteristic is of great potential clinical relevance given that, historically, planktonically grown bacteria have been considered to be the most antibiotic sensitive. Unfortunately it is the planktonic bacterial lifestyle that is relied upon to determine treatment protocols that too often fail when attempting to eradicate biofilm-resident bacteria. After &#x03B1;-DNABII-induced biofilm disruption, we too have characterized a phenotype of significantly increased antibiotic susceptibility in bacteria newly released from biofilms formed by any of 24 diverse genera of pathogens, including all members of the high priority and multiple-antibiotic-resistant ESKAPEE pathogens (<xref ref-type="bibr" rid="B43">Mokrzan et al., 2018</xref>, <xref ref-type="bibr" rid="B42">2020</xref>; <xref ref-type="bibr" rid="B30">Kurbatfinski et al., 2022</xref>, <xref ref-type="bibr" rid="B31">Kurbatfinski et al., 2023a</xref>,<xref ref-type="bibr" rid="B32">b</xref>; <xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>). While we have not yet fully elucidated all of the molecular mechanisms that underlie the marked sensitivity of &#x03B1;-DNABII NTHI NRel to antibiotic killing, we have previously reported that they appear to be in canonical lag phase of growth and exhibit both significantly increased outer membrane permeability and significantly downregulated expression of at least two genes involved in mediation of oxidative stress compared to planktonic NTHI, among other findings (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>).</p>
<p>In addition to its <italic>in vitro</italic> disruptive capability, we have shown in four distinct pre-clinical models of human disease that &#x03B1;-DNABII treatment facilitates significant disease-resolution efficacy. Therapeutic treatment with &#x03B1;-DNABII resolves mucosal biofilms formed by <italic>Aggregatibacter actinomycetemcomitans</italic> in a rat osteolytic peri-implantitis model (<xref ref-type="bibr" rid="B16">Freire et al., 2017</xref>), facilitates clearance of aggregate <italic>Pseudomonas aeruginosa</italic> and <italic>Mycobacterium abscessus</italic> biofilms from the murine lung (<xref ref-type="bibr" rid="B25">Jurcisek et al., 2025</xref>, <xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>), and antigen-binding fragments derived from a humanized &#x03B1;-DNABII mAb mediate resolution of nontypeable <italic>Haemophilus influenzae</italic> (NTHI)-induced otitis media in the chinchilla middle ear (<xref ref-type="bibr" rid="B46">Novotny et al., 2021</xref>). Preventatively, active immunization of chinchillas with the tip-chimer peptide itself induces formation of antibodies that effectively disrupt existing NTHI biofilms in the middle ear, which ultimately leads to rapid resolution of experimental otitis media (<xref ref-type="bibr" rid="B47">Novotny et al., 2019</xref>).</p>
<p>Intriguingly, after therapeutic treatment with &#x03B1;-DNABII, the rapid biofilm eradication and disease resolution we observed in each of these pre-clinical models occurred without use of added antibiotics. This common outcome suggested to us that the primary means of infection resolution was likely due to the action of innate immune effectors. As such, we wondered whether NTHI newly released from biofilm residence by &#x03B1;-DNABII (i.e., &#x201C;&#x03B1;-DNABII NTHI NRel&#x201D;) might, in addition to being significantly more susceptible to both antibiotic- and antimicrobial peptide-mediated killing, also display a phenotype of increased susceptibility to human PMNs, which arrive rapidly at infection sites (<xref ref-type="bibr" rid="B36">Liew and Kubes, 2019</xref>). Whereas both planktonic and biofilm resident NTHI have been shown to resist killing by PMNs (<xref ref-type="bibr" rid="B22">Hong et al., 2009</xref>; <xref ref-type="bibr" rid="B23">Juneau et al., 2011</xref>), which includes the ability of biofilm-resident NTHI to utilize DNABII proteins in an offensive manner to convert native NET B-form DNA to the rare Z-form and thereby abrogate NET killing function (<xref ref-type="bibr" rid="B6">Buzzo et al., 2021</xref>), we&#x2019;ve shown that NRel NTHI are significantly more susceptible to killing by human PMNs in an NADPH-oxidase sensitive manner (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>), which is likely related to the fact that &#x03B1;-DNABII NTHI NRel exhibit significantly downregulated expression of gene products involved in their ability to mediate oxidative stress (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>).</p>
<p>This is not surprising given that there have been multiple reports which characterize the highly unique phenotype of bacterial cells that have newly dispersed from biofilm residence (<xref ref-type="bibr" rid="B55">Rollet et al., 2009</xref>; <xref ref-type="bibr" rid="B9">Chua et al., 2014</xref>; <xref ref-type="bibr" rid="B3">Barraud et al., 2015</xref>; <xref ref-type="bibr" rid="B26">Kalia and Sauer, 2024</xref>). As such, we were interested in how human PMNs responded when incubated with either planktonically grown NTHI, those NTHI newly released from biofilm residence by anti-DNABII or NTHI that were present in the medium that overlaid a biofilm. The latter population was hypothesized to be more similar to those bacteria found in disease sites such as a middle ear effusion or within synovial fluid of an infected joint than those grown planktonically and heretofore will be referred to as non-biofilm associated (&#x201C;NBfA&#x201D;) NTHI. Herein, via timelapse microscopy and flow cytometry analysis, we qualified and quantified, respectively, human PMN uptake of NTHI, NETosis, and migratory activity when incubated with each of these three NTHI populations. We also monitored for relative concentrations of both NTHI endotoxin and DNA within the fluids in which these populations were suspended when incubated with PMNs as both are known to induce NETosis (<xref ref-type="bibr" rid="B23">Juneau et al., 2011</xref>). Further, we assayed for the relative release of chemokines/cytokines by PMNs when incubated with each of the three tested NTHI populations.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="S2.SS1">
<title>Ethics</title>
<p>De-identified human blood donations provided by healthy adult subjects that span the demographic spectrum of central Ohio were made under the auspices of the Research Institute Blood Donor Services of Nationwide Children&#x2019;s Hospital after informed written consent was obtained. PMNs were isolated from these blood specimens for use in studies conducted within our laboratory in conformity with, and as approved under, Nationwide Children&#x2019;s Hospital Institutional Biosafety Committee (IBC) protocol #IBS-00000449. All experiments were conducted in accordance with relevant guidelines and regulations of the Nationwide Children&#x2019;s Hospital Research Institute Blood Donor Services and Institutional Biosafety Committee.</p>
</sec>
<sec id="S2.SS2">
<title>Bacterial strains and growth</title>
<p>Nontypeable <italic>Haemophilus influenzae</italic> (NTHI) strain 86-028NP (<xref ref-type="bibr" rid="B60">Sirakova et al., 1994</xref>) was maintained frozen in LN<sub>2</sub> at passage #4 on artificial medium since its original isolation from the nasopharynx of a child who underwent tympanostomy tube insertion due to chronic otitis media. For fluorescent timelapse microscopy and flow cytometry, GFP-expressing NTHI 86-028NP/pRSM2211 (<xref ref-type="bibr" rid="B38">Mason et al., 2003</xref>) was utilized. NTHI strains 1128 and 1728, also isolated from children with chronic otitis media (<xref ref-type="bibr" rid="B2">Bakaletz et al., 1988</xref>) had been maintained in LN<sub>2</sub> at passage #4 or #7, respectively. All NTHI strains were grown in Brain Heart Infusion (Thermo Fisher Scientific, Waltham, MA) broth supplemented with hemin (2 &#x03BC;g/mL) (Sigma-Aldrich, St. Louis, MO) and &#x03B2;-NAD (2 &#x03BC;g/mL) (Sigma-Aldrich) (e.g., sBHI) or on chocolate agar (Thermo Fisher Scientific) at 37 &#x00B0;C with 5% CO<sub>2</sub> in a humidified atmosphere.</p>
</sec>
<sec id="S2.SS3">
<title>PMN isolation and preparation</title>
<p>Human neutrophils were isolated from whole blood via magnetic negative selection using the EasySep&#x2122; Direct Human Neutrophil Isolation Kit (StemCell Technologies, Inc., Vancouver, Canada). The final PMN pellet was resuspended in 1 mL HBSS (Thermo Fisher Scientific) and total number PMNs/mL HBSS enumerated before making separate solutions of 1e6 PMNs/mL HBSS for timelapse microscopy or 2e6 PMNs/mL HBSS for flow cytometry.</p>
</sec>
<sec id="S2.SS4">
<title>Antibodies</title>
<p>A murine monoclonal antibody of the IgG isotype against a 44-mer tip-chimer peptide designed to mimic protective epitopes of the DNA-binding &#x201C;tips&#x201D; of the alpha and beta subunits of a bacterial DNABII protein were prepared for us under contract to Rockland Immunochemicals, Inc., (Philadelphia, PA) and has been previously characterized (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>). This monoclonal antibody is referred herein as &#x201C;MsTipMab.&#x201D;</p>
</sec>
<sec id="S2.SS5">
<title>Collection of &#x03B1;-DNABII NRel, NBfA, or planktonic NTHI</title>
<p>For NTHI 86-028NP/pRSM2211 or 1728, biofilms were established as previously described (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>) after seeding 10 cm<sup>2</sup> flat tissue culture tubes (TPP, Trasadingen, Switzerland) with 2e5 CFU/mL solution for 16 h. As NTHI 1128 exhibited growth approximately two times that of either NTHI 86-028NP/pRSM2211 or 1728 (as evidenced by growth curve analysis), NTHI 1128 was seeded as previously described (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>) but at 1e5 CFU/mL. Regardless of NTHI strain, after 16 h biofilms were gently washed to remove non-adherent bacterial cells prior to incubation for 2 h with 5 &#x03BC;g MsTipMab diluted in sBHI/0&#x22C5;8 cm<sup>2</sup> at 37 &#x00B0;C with 5% CO<sub>2</sub> in a humidified atmosphere for collection of &#x03B1;-DNABII NTHI NRel. Planktonically grown NTHI 86-028NP/pRSM2211 or 1728 were allowed to grow statically in sBHI broth at 37 &#x00B0;C with 5% CO<sub>2</sub> in a humidified atmosphere for 3 h which was pre-determined to be mid-log phase. NTHI 1128 was allowed to grow statically at 37 &#x00B0;C with 5% CO<sub>2</sub> in a humidified atmosphere for 1.5 h to mid-log phase due to the faster rate of growth of this isolate. To prepare lag phase planktonically grown bacteria, NTHI 86-028NP/pRSM2211 or 1728 were allowed to grow statically in sBHI at 37 &#x00B0;C with 5% CO<sub>2</sub> in a humidified atmosphere for 1 h to mid-lag phase. NTHI 1128 was allowed to grow statically in sBHI at 37 &#x00B0;C with 5% CO<sub>2</sub> in a humidified atmosphere for 30 m to mid-lag phase. Growth phase status was pre-determined for all three NTHI isolates by conducting overnight growth curves. To generate NBfA, NTHI biofilms were established in flat tissue culture tubes for 16 h, gently washed to remove non-adherent bacteria, then incubated for 2 h with 1.25 mL sBHI only before collecting NBfA bacteria present within the fresh media above the biofilm, as previously described (<xref ref-type="bibr" rid="B5">Boisvert et al., 2016</xref>; <xref ref-type="bibr" rid="B29">Kragh et al., 2023</xref>; <xref ref-type="bibr" rid="B68">Zhao et al., 2023</xref>).</p>
</sec>
<sec id="S2.SS6">
<title>Fluorescent labeling of NTHI</title>
<p>For fluorescent timelapse microscopy and flow cytometry, all NTHI bacterial populations were collected and centrifuged for 3 m at 14,000 rpm at 4 &#x00B0;C. Bacterial pellets were resuspended in 400 &#x03BC;L 0.1M sodium bicarbonate buffer at pH 8.4, centrifuged as before, resuspended in 0.1M sodium bicarbonate buffer, then sonicated for 2 m in a water bath sonicator (Branson Ultrasonics Corporation, Brookfield, CT). All NTHI strains were then labeled with the red fluorescing pH-sensitive dye, pHrodo&#x2122; Red, SE (Thermo Fisher Scientific), per manufacturer&#x2019;s instructions for 30 m at room temperature, protected from light. pHrodo&#x2122; Red SE is a pH-sensitive dye that only fluoresces in acidic environments, such as within a phagolysosome where the pH can reach &#x2264;5.0 (<xref ref-type="bibr" rid="B34">Lee et al., 2003</xref>), and thus was utilized as an indicator of successful PMN engulfment. After 30 m, for NTHI strains 1128 and 1728 that do not express GFP, these bacterial populations were then also labeled with green fluorescent membrane stain FilmTracer FM&#x2122; 1-43 (Invitrogen, Waltham, MA) per manufacturer&#x2019;s instructions for 15 m at room temperature and protected from light. For strain 86-028NP, we used a constitutive GFP-expressing reporter, (NTHI 86-028NP/pRSM2211), hence referred to as &#x201C;NTHI 86-028NP&#x201D; for simplicity (<xref ref-type="bibr" rid="B2">Bakaletz et al., 1988</xref>, <xref ref-type="bibr" rid="B1">1997</xref>; <xref ref-type="bibr" rid="B60">Sirakova et al., 1994</xref>; <xref ref-type="bibr" rid="B10">DeMaria et al., 1996</xref>; <xref ref-type="bibr" rid="B41">Miyamoto and Bakaletz, 1996</xref>; <xref ref-type="bibr" rid="B45">Novotny and Bakaletz, 2003</xref>). Dual labeling of NTHI strains 1128 and 1728 with FilmTracer FM&#x2122; 1-43 was used to ensure that engineering of NTHI 86-028NP/pRSM211 to report GFP was not responsible for the NRel phenotypes observed.</p>
<p>After the labeling periods, all NTHI bacterial populations were centrifuged for 3m at 14,000 rpm at 4 &#x00B0;C. Bacterial pellets were resuspended in 400 &#x03BC;L 0.1M sodium bicarbonate buffer at pH 8.4, centrifuged as before, and the process repeated for a total of two buffer washings. Bacterial pellets were finally resuspended in 0.1M sodium bicarbonate buffer to 1e6 CFU/mL for microscopy or to 4e6 CFU/mL in 0.1M sodium bicarbonate buffer for flow cytometry. Green fluorescent labeling intensity did not differ between NTHI that reported GFP (strain 86-028NP) and those that were labeled with green FilmTracerFM&#x2122; (strains 1128 and 1728) during the duration of any of the studies conducted herein, however equivalent photo bleaching would occur for either with prolonged imaging. To ensure similar CFU NTHI/mL were added into each assay, and to ensure bacterial viability, all fluorescently labeled bacterial populations were diluted and plated for CFU determination.</p>
</sec>
<sec id="S2.SS7">
<title>Timelapse microscopy</title>
<p>Nontypeable <italic>Haemophilus influenzae</italic> (NTHI) bacterial solutions at 1e6 CFU/mL were sonicated for 2m in a water bath sonicator before spotting 10 &#x03BC;L of each bacterial population into separate quadrants of a 4-chambered glass bottom dish (Cellvis, Mountain View, CA). &#x03B1;-DNABII NTHI NRel, NBfA, or planktonically grown NTHI were allowed to adhere to the glass for 30 m at room temperature in a humidified atmosphere before imaging. Immediately before imaging, fluids of the 10 &#x03BC;L droplet were carefully pipetted away, then 10 &#x03BC;L PMN solution at 1e6 PMNs/mL was added. Imaging began as soon as PMNs were added to bacterial spots at 100x magnification on a Nikon Ti2-E White Light inverted microscope (Nikon Instruments Inc., Melville, NY). Images were captured every 30 s until we were able to visualize over-saturation of pHrodo&#x2122; red fluorescence. The imaging periods were restricted to a constant period of time for each of the three NTHI strains to allow us to visually detect fluorescence differences amongst the three bacterial populations for each strain before we lost the ability to discriminate relative fluorescence by eye. Due to the inherent heterogeneity of NTHI (<xref ref-type="bibr" rid="B14">Duell et al., 2016</xref>), this translated to a total of 10 m for NTHI 86-028NP, 20 m for NTHI 1728, and 35 m for NTHI 1128. All assays were conducted at four separate times and on four separate days for each NTHI strain. Images and videos shown are representative of the independent assays. Microscopy data were processed and analyzed via NIS Elements software and arbitrary red fluorescence intensity in units (AFU) was analyzed with an NIS Elements General Analysis program (v. 5.42.03) (Nikon Instruments Inc.) and reported as arbitrary fluorescence units (AFU). To determine and normalize fluorescence, any background fluorescence at time 0 was removed for each individual bacterial population of each of the 3 NTHI isolates tested, and each strain was imaged separately for a set amount of time, e.g., 10, 20, or 35 min. Mean influx values in <xref ref-type="table" rid="T1">Table 1</xref> were calculated from all raw data collected from replicate runs for each bacterial population and each strain.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Migration of additional PMNs into the FOV was greatest in cultures of PMNs incubated with &#x03B1;-DNABII NRel of all three NTHI strains.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">Bacterial population and NTHI strain</th>
<th valign="top" align="center">Number of PMNs in FOV at 0 min average &#x00B1; SEM</th>
<th valign="top" align="center">Number of PMNs in FOV at 10 min average &#x00B1; SEM</th>
<th valign="top" align="center">Influx of PMNs within 10 min average &#x00B1; SEM</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Planktonic 86-028NP</td>
<td valign="top" align="center">8 &#x00B1; 2</td>
<td valign="top" align="center">22 &#x00B1; 4</td>
<td valign="top" align="center">15 &#x00B1; 4</td>
</tr>
<tr>
<td valign="top" align="left">NBfA 86-028NP</td>
<td valign="top" align="center">8 &#x00B1; 4</td>
<td valign="top" align="center">42 &#x00B1; 6</td>
<td valign="top" align="center">34 &#x00B1; 3<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x03B1;-DNABII NRel<break/> 86-028NP</td>
<td valign="top" align="center">12 &#x00B1; 2</td>
<td valign="top" align="center">63 &#x00B1; 8</td>
<td valign="top" align="center">50 &#x00B1; 9<xref ref-type="table-fn" rid="t1fns1">&#x002A;&#x002A;&#x002A;,<sup>&#x2020;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">Planktonic 1128</td>
<td valign="top" align="center">8 &#x00B1; 1</td>
<td valign="top" align="center">13 &#x00B1; 2</td>
<td valign="top" align="center">6 &#x00B1; 2</td>
</tr>
<tr>
<td valign="top" align="left">NBfA 1128</td>
<td valign="top" align="center">6 &#x00B1; 2</td>
<td valign="top" align="center">26 &#x00B1; 6</td>
<td valign="top" align="center">20 &#x00B1; 5<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x03B1;-DNABII NRel 1128</td>
<td valign="top" align="center">8 &#x00B1; 2</td>
<td valign="top" align="center">39 &#x00B1; 3</td>
<td valign="top" align="center">31 &#x00B1; 1<xref ref-type="table-fn" rid="t1fns1">&#x002A;&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Planktonic 1728</td>
<td valign="top" align="center">6 &#x00B1; 1</td>
<td valign="top" align="center">16 &#x00B1; 2</td>
<td valign="top" align="center">10 &#x00B1; 2</td>
</tr>
<tr>
<td valign="top" align="left">NBfA 1728</td>
<td valign="top" align="center">9 &#x00B1; 1</td>
<td valign="top" align="center">31 &#x00B1; 3</td>
<td valign="top" align="center">22 &#x00B1; 2<xref ref-type="table-fn" rid="t1fns1">&#x002A;&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x03B1;-DNABII NRel 1728</td>
<td valign="top" align="center">10 &#x00B1; 2</td>
<td valign="top" align="center">41 &#x00B1; 3</td>
<td valign="top" align="center">31 &#x00B1; 1<xref ref-type="table-fn" rid="t1fns1">&#x002A;&#x002A;&#x002A;,<sup>&#x2020;</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1fns1"><p><sup>a</sup>&#x201C;NBfA&#x201D; refers to non-biofilm associated bacteria; &#x201C;&#x03B1;-DNABII NRel&#x201D; refers to bacteria newly released from biofilms via the action of a DNABII-directed monoclonal antibody. <italic><sup>b</sup></italic>Stars indicate significance between that population compared to planktonic bacteria within each individual NTHI strain. <italic><sup>c</sup></italic>Dagger indicates significance between that population compared to NBfA within each individual NTHI strain. <sup>d,</sup>&#x002A;,<sup>&#x2020;</sup><italic>p</italic> &#x2264; 0.05, &#x002A;&#x002A;<italic>p</italic> &#x2264; 0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x2264; 0.001.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S2.SS8">
<title>Flow cytometry</title>
<p>Bacterial solutions at 2e6 CFU/mL were sonicated for 2 m in a water bath sonicator to disrupt any aggregates, then 500 &#x03BC;L each bacterial solution was carefully added into wells of the 24-well plate such that 2e6 CFU/mL was added to wells that contained 500 &#x03BC;L of a 2e6 PMNs/mL solution. Samples were analyzed with a BD LSRFortessa flow cytometer (BD Biosciences, Franklin Lakes, NJ). Flow cytometry data were analyzed with FloJo software (v. 10.10.0) (FloJo, LLC, Ashland, OR). All flow cytometry was performed at least three separate times on at least three separate days for all populations of each NTHI strain.</p>
</sec>
<sec id="S2.SS9">
<title>Endotoxin quantification</title>
<p>After NTHI populations were prepared and fluorescently labeled, the sodium bicarbonate buffer-bacterial suspensions were filter sterilized with a 0.22 &#x03BC;m syringe filter and the bacterial cell-free solutions were immediately subjected to endotoxin quantification via the Thermo Scientific&#x2122; Pierce&#x2122; Chromogenic Endotoxin Quant Kit (Thermo Fisher Scientific). Endotoxin quantification was performed per manufacturer&#x2019;s instructions. Sterility was confirmed by spread plating on chocolate agar. Data represent the mean &#x00B1; SEM of three biological replicates that were repeated on three separate days for each NTHI strain.</p>
</sec>
<sec id="S2.SS10">
<title>DNA quantification</title>
<p>Quantification of relative extracellular DNA concentration within bacterial cell-free filter sterilized solutions in which each bacterial population had been suspended for incubation with human PMNs was performed via the Qubit dsDNA HS Assay Kit per manufacturer&#x2019;s instructions (Thermo Fisher Scientific).</p>
</sec>
<sec id="S2.SS11">
<title>Cytokine/chemokine analysis</title>
<p>Cytokine and chemokine assessment was performed via BD&#x2122; Cytometric Bead Array (CBA) Human Inflammatory Cytokine Cytometric Bead Array (CBA) &#x2013; I Kit (BD Biosciences) or with BD&#x2122; Cytometric Bead Array (CBA) Human Flex Sets (BD Biosciences). To generate samples, the methodology we used to prepare NTHI populations for flow cytometry experiments was repeated. The 1 mL PMN-NTHI solution was collected after 10 m of co-incubation. Cytokine/chemokine analysis was performed immediately according to manufacturer&#x2019;s instructions on an Accuri C6 flow cytometer (BD Biosciences) and data analyzed with FCAP Array&#x2122; Software v3.0.19.2091 (BD Biosciences). Data represent the mean &#x00B1; SEM of three biological replicates that were repeated on three separate days for each NTHI strain.</p>
</sec>
<sec id="S2.SS12">
<title>Statistics</title>
<p>Statistical tests were performed with GraphPad Prism 10 for all <italic>in vitro</italic> assays. Due to small sample sizes, a Shapiro-Wilk test for normality was performed on all data as well as a nonparametric Kruskal-Wallis test [with an uncorrected (i.e., non-parametric) Dunn&#x2019;s test for multiple comparisons] to ensure that any stated statistical significance with parametric one-way ANOVAs (with Dunnett&#x2019;s multiple comparison correction) (or lack thereof) were retained. Results from parametric testing are retained when data were normally distributed, and non-parametric test outcomes are reported for data that were not normally distributed. Data are presented as mean &#x00B1; SEM and significance is shown as &#x002A;<italic>p</italic> &#x2264; 0.05, &#x002A;&#x002A;<italic>p</italic> &#x2264; 0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x2264; 0.001, and &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x2264; 0.0001. The number of biological replicates is defined within respective figure legends.</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<title>Results</title>
<sec id="S3.SS1">
<title>Regardless of NTHI strain, PMNs incubated with pHrodo&#x2122;-labeled NTHI populations demonstrated the greatest engulfment and NETosis activity with &#x03B1;-DNABII NTHI NRel</title>
<p>When incubated with mid-log phase planktonically grown NTHI 86-028NP, all PMNs in the field of view (FOV) exhibited uptake activity throughout the 10 min imaging period as evidenced by PMNs that turned a light red color in addition to observing that a few PMNs began to exhibit NETosis activity, as assessed by visual loss of cellular membrane integrity (<xref ref-type="fig" rid="F1">Figures 1A&#x2013;C</xref>). When average arbitrary fluorescence intensity was quantified at the end of the imaging period, PMNs incubated with planktonic NTHI 86-028NP exhibited 98 arbitrary fluorescence units (AFU) (<xref ref-type="table" rid="T2">Table 2</xref>). When incubated with NBfA NTHI 86-028NP, all PMNs in the FOV engulfed NTHI and, in contrast to what we observed with planktonic NTHI 86-028NP, there was rapid (within 1&#x2013;2 m) NETosis activity by the majority of PMNs that was evidenced by bright red fluorescence as demonstrated by approximately half of the PMNs in the FOV. This outcome yielded an average of 142 AFU (<xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref> and <xref ref-type="table" rid="T2">Table 2</xref>). Intriguingly, PMNs incubated with &#x03B1;-DNABII NTHI 86-028NP NRel exhibited the most rapid uptake and NETosis activity, as well as the most striking red fluorescence with an average of 197 AFU which was significantly greater than that observed with either planktonic or NBfA populations (<italic>p</italic> &#x2264; 0.05&#x2013;0.01) (<xref ref-type="fig" rid="F1">Figures 1G&#x2013;I</xref> and <xref ref-type="table" rid="T2">Table 2</xref>). In addition to images presented within <xref ref-type="fig" rid="F1">Figure 1</xref>, relative PMN activity was documented by video microscopy (<xref ref-type="supplementary-material" rid="VS1">Supplementary Videos 1</xref>&#x2013;<xref ref-type="supplementary-material" rid="VS3">3</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Relative PMN activity when incubated with three distinct populations of pHrodo&#x2122;-labeled NTHI 86-028NP/pRSM2211. By timelapse microscopy, there was evidence of PMN-mediated uptake and NETosis when PMNs were incubated with planktonic <bold>(A&#x2013;C)</bold>, NBfA <bold>(D&#x2013;F)</bold>, or &#x03B1;-DNABII NRel <bold>(G&#x2013;I)</bold> NTHI. Uptake, NETosis, and red fluorescence was visually greatest upon co-incubation of PMNs with &#x03B1;-DNABII NRel <bold>(G&#x2013;I)</bold>. Results are representative of four separate assays. Similar results were also seen with two additional clinical isolates of NTHI (see <xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1</xref>). Collectively, these data indicated greatest PMN engulfment and NETosis activity was observed specifically with &#x03B1;-DNABII NRel NTHI.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1728903-g001.tif">
<alt-text content-type="machine-generated">A 3-by-3 panel figure compares human PMN uptake and NETosis activity when incubated with planktonic (A-C), NBfA (D-F), or &#x03B1;-DNABII NRel (G-I) NTHI 86-028NP/pRSM2211. PMN activity was greatest with &#x03B1;-DNABII NRel NTHI, as evidenced by greatest red fluorescence and most NETosis activity. Similar results were also seen with two additional clinical isolate of NTHI (see Supplementary Figure 1).</alt-text>
</graphic>
</fig>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Mean arbitrary red fluorescence units &#x00B1; SEM emitted by PMNs when incubated with three NTHI strains and populations.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">NTHI strain</th>
<th valign="top" align="center" colspan="3">Mean arbitrary fluorescence units (AFU) &#x00B1; SEM</th>
</tr>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Planktonic</th>
<th valign="top" align="center">NBfA</th>
<th valign="top" align="center">&#x03B1;-DNABII NRel</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">86-028NP</td>
<td valign="top" align="center">98 &#x00B1; 20</td>
<td valign="top" align="center">142 &#x00B1; 23</td>
<td valign="top" align="center">197 &#x00B1; 19<xref ref-type="table-fn" rid="t2fns1">&#x002A;&#x002A;,<sup>&#x2020;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">1128</td>
<td valign="top" align="center">104 &#x00B1; 12</td>
<td valign="top" align="center">163 &#x00B1; 13</td>
<td valign="top" align="center">249 &#x00B1; 17<xref ref-type="table-fn" rid="t2fns1">&#x002A;&#x002A;&#x002A;,<sup>&#x2020;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">1728</td>
<td valign="top" align="center">104 &#x00B1; 11</td>
<td valign="top" align="center">145 &#x00B1; 7<xref ref-type="table-fn" rid="t2fns1">&#x002A;</xref></td>
<td valign="top" align="center">282 &#x00B1; 8<xref ref-type="table-fn" rid="t2fns1">&#x002A;&#x002A;&#x002A;&#x002A;,<sup>&#x2020;&#x2020;&#x2020;</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t2fns1"><p><sup>a</sup>&#x201C;NBfA&#x201D; refers to non-biofilm associated bacteria; &#x201C;&#x03B1;-DNABII NRel&#x201D; refers to bacteria newly released from biofilms via the action of a DNABII-directed monoclonal antibody. <italic><sup>b</sup></italic>Stars indicate significance between that population compared to planktonic bacteria within each individual NTHI strain. <italic><sup>c</sup></italic>Dagger(s) indicate(s) significance between that population compared to NBfA within each individual NTHI strain. <sup>d,</sup>&#x002A;<sup>&#x2020;</sup><italic>p</italic> &#x2264; 0.05, &#x002A;&#x002A;<italic>p</italic> &#x2264; 0.01, &#x002A;&#x002A;&#x002A;,<sup>&#x2020;&#x2063;&#x2020;&#x2063;&#x2020;</sup> <italic>p</italic> &#x2264; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x2264; 0.0001.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>When assayed with the second NTHI isolate, all PMNs in the FOV incubated with log phase planktonically grown NTHI 1128 exhibited rapid uptake activity throughout the 35 min imaging period wherein most PMNs exhibited a light red color. In addition, a few PMNs exhibited NETosis activity, which was similar to PMN activity with planktonic NTHI 86-028NP as reported above. PMNs incubated with NTHI 1128 that had been planktonically grown yielded an average of 104 AFU (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1A</xref>, panels a&#x2013;c and <xref ref-type="table" rid="T2">Table 2</xref>). When incubated with NBfA NTHI 1128, all PMNs exhibited both uptake and rapid NETosis activity, with bright visual red fluorescence detected in most PMNs in the FOV for an average of 168 AFU (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1A</xref>, panels d&#x2013;f and <xref ref-type="table" rid="T2">Table 2</xref>). When incubated with &#x03B1;-DNABII NTHI NRel of strain 1128, we again observed rapid uptake and NETosis activity within 2.5&#x2013;3 min, as well as the most robust and striking visual red fluorescence with an average of 247 AFU which was significantly greater than that observed with either planktonic or NBfA populations (<italic>p</italic> &#x2264; 0.05&#x2013;0.001) (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1A</xref>, panels g&#x2013;i and <xref ref-type="table" rid="T2">Table 2</xref>). In addition to images presented within <xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1A</xref>, relative PMN activity was documented by video microscopy (<xref ref-type="supplementary-material" rid="VS4">Supplementary Videos 4</xref>&#x2013;<xref ref-type="supplementary-material" rid="VS6">6</xref>).</p>
<p>When incubated with the third assessed NTHI strain, 1728, we observed engulfment and NETosis activity by PMNs incubated with mid-log phase planktonically grown NTHI 1728, and a few PMNs exhibited a light red color with an average of 109 AFU by the end of the imaging period (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1B</xref>, panels a&#x2013;c and <xref ref-type="table" rid="T2">Table 2</xref>). When incubated with NBfA NTHI 1728, we observed both rapid PMN uptake and NETosis activity, and bright red fluorescence detected in approximately half of the PMNs in the FOV with an average of 143 AFU (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1B</xref>, panels d&#x2013;f and <xref ref-type="table" rid="T2">Table 2</xref>). As seen with the other two NTHI isolates, PMNs incubated with &#x03B1;-DNABII NTHI 1728 NRel exhibited the most rapid uptake and NETosis activities as well as the greatest visual red fluorescence in approximately half the PMNs in the FOV, with an average of 287 AFU which was significantly greater than that observed with either planktonic or NBfA populations (<italic>p</italic> &#x2264; 0.05&#x2013;0.0001) (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1B</xref>, panels g&#x2013;i and <xref ref-type="table" rid="T2">Table 2</xref>). In addition to images presented within <xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1B</xref>, relative PMN activity was documented by video microscopy (<xref ref-type="supplementary-material" rid="VS7">Supplementary Videos 7</xref>&#x2013;<xref ref-type="supplementary-material" rid="VS9">9</xref>).</p>
</sec>
<sec id="S3.SS2">
<title>PMNs incubated with pHrodo&#x2122;-labeled &#x03B1;-DNABII NTHI NRel exhibited the rightmost shift in red fluorescence by flow cytometry</title>
<p>As our observations were primarily subjective to this point, to objectively detect and quantify relative red fluorescence by an additional methodology, we assessed the relative red fluorescence of PMNs collected after co-incubation with pHrodo&#x2122; Red SE-labeled planktonic, NBfA, or &#x03B1;-DNABII NRel NTHI populations via flow cytometry. In all cases, PMNs without bacteria served as the negative control and exhibited peak average red fluorescence of approximately 70 (<xref ref-type="fig" rid="F2">Figure 2</xref>, black histograms). PMNs incubated with planktonically grown NTHI 86-028NP exhibited a slight right shift in peak red fluorescence, with a mean emission of approximately 5 &#x00D7; 10<sup>2</sup> (<xref ref-type="fig" rid="F2">Figure 2A</xref>, brown histograms), whereas those incubated with NBfA NTHI 86-028NP exhibited a greater right shift with a peak mean of approximately 2 &#x00D7; 10<sup>3</sup> (<xref ref-type="fig" rid="F2">Figure 2A</xref>, orange histograms). In keeping with data obtained by timelapse microscopy, the greatest and rightmost shift in red fluorescence was exhibited by PMNs incubated with &#x03B1;-DNABII NTHI NRel, wherein peak average red fluorescence was &#x223C;1x10<sup>4</sup> (<xref ref-type="fig" rid="F2">Figure 2A</xref>, yellow histograms).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>PMNs incubated with pHrodo&#x2122;-labeled &#x03B1;-DNABII NTHI NRel exhibited the rightmost shift in red fluorescence by flow cytometry. Analysis of relative shifts in red fluorescence by PMNs incubated with pHrodo&#x2122;-labeled planktonically grown, NBfA, or &#x03B1;-DNABII NTHI NRel via flow cytometry. PMNs without bacteria (black histograms) served as the negative control. Regardless of NTHI strain, PMNs incubated with planktonically grown (red histograms) NTHI 86-028NP <bold>(A)</bold>, NTHI 1128 <bold>(B)</bold>, or NTHI 1728 <bold>(C)</bold> exhibited a slight right shift in red fluorescence relative to the negative control. Relative red fluorescence was greater when incubated with NBfA of any NTHI isolate (orange histograms), however, overall greatest red fluorescence was seen in PMNs incubated with &#x03B1;-DNABII NTHI NRel (yellow histograms), thereby corroborating timelapse microscopy data. Results are representative of 3 independently run assays.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1728903-g002.tif">
<alt-text content-type="machine-generated">By flow cytometry, pHrodo&#x2122;-labeled &#x03B1;-DNABII NRel NTHI exhibited the rightmost shift in red fluorescence. PMNs without bacteria (black histograms) served as the negative control. Regardless of NTHI strain, PMNs incubated with planktonically grown (red histograms) NTHI 86-028NP (A), NTHI 1128 (B), or NTHI 1728 (C) exhibited a slight right shift in red fluorescence relative to the negative control. Relative red fluorescence greater and showed an increased right shift when incubated with NBfA of any NTHI isolate (orange histograms). Overall greatest red fluorescence and the greatest right shift in red fluorescence was seen in PMNs incubated with &#x03B1;-DNABII NTHI NRel (yellow histograms), corroborating timelapse microscopy data.</alt-text>
</graphic>
</fig>
<p>When incubated with planktonically grown NTHI 1128, PMNs exhibited a slight right shift in red fluorescence compared to PMNs without bacteria, with the mean peak at approximately 7 &#x00D7; 10<sup>2</sup> (<xref ref-type="fig" rid="F2">Figure 2B</xref>, brown histograms). When incubated with NBfA NTHI 1128, PMNs exhibited a mean red fluorescence of approximately 2 &#x00D7; 10<sup>4</sup> (<xref ref-type="fig" rid="F2">Figure 2B</xref>, orange histograms), and again the greatest right shift in peak average red fluorescence of approximately 3x10<sup>4</sup> when incubated with &#x03B1;-DNABII NRel NTHI (<xref ref-type="fig" rid="F2">Figure 2B</xref>, yellow histograms).</p>
<p>With the last of three clinical isolates assessed, PMNs incubated with planktonically grown NTHI 1728 exhibited a slight increase in red fluorescence relative to PMNs without bacteria, with an average peak of 2 &#x00D7; 10<sup>3</sup> (<xref ref-type="fig" rid="F2">Figure 2C</xref>, brown histograms). When incubated with NBfA NTHI 1728 the average red fluorescence occurred at &#x223C;2 &#x00D7; 10<sup>4</sup> (<xref ref-type="fig" rid="F2">Figure 2C</xref>, orange histograms). The greatest right shift again occurred with PMNs incubated with &#x03B1;-DNABII NTHI 1728 NRel, wherein a peak average of approximately 4 &#x00D7; 10<sup>4</sup> was obtained (<xref ref-type="fig" rid="F2">Figure 2C</xref>, yellow histograms). While there was variability in relative placement of red fluorescence peaks, the rightmost shift in red fluorescence was consistently observed when PMNs were co-cultured with &#x03B1;-DNABII NTHI NRel of all three strains tested, which aligned well with what we observed by timelapse microscopy.</p>
</sec>
<sec id="S3.SS3">
<title>Migration of additional PMNs into the FOV was greatest in cultures of PMNs incubated with &#x03B1;-DNABII NRel, regardless of NTHI strain</title>
<p>From our microscopy assays, in addition to PMN engulfment and NETosis activity, we observed that the relative movement of additional PMNs into the initial FOV, which were selected to ensure approximately the same number of PMNs at time 0 min for each NTHI strain and population tested, appeared distinct amongst the three bacterial populations. To investigate this further, we quantified the number of additional PMNs that migrated into a FOV when incubated with all three populations of the three NTHI strains.</p>
<p>When incubated with NTHI 86-028NP, the number of additional PMNs that entered the FOV within 10 min was: 15 &#x00B1; 4 for planktonic NTHI, 34 &#x00B1; 3 with NBfA which were statistically significant compared to planktonic (<italic>p</italic> = 0.02), and 50 &#x00B1; 9 with &#x03B1;-DNABII NRel which was also statistically significant (<italic>p</italic> = 0.0008) (<xref ref-type="table" rid="T1">Table 1</xref>). For NTHI strain 1128, we observed similar results with the following number of additional PMNs having migrated into the FOV within 10 min when incubated with planktonic, NBfA, or NRel: 6 &#x00B1; 2, 20 &#x00B1; 5, and 31 &#x00B1; 1, respectively, with the latter two values being statistically significant (<italic>p</italic> = 0.09, <italic>p</italic> = 0.004, respectively) compared to PMNs incubated with planktonic NTHI 1128 (<xref ref-type="table" rid="T1">Table 1</xref>). For NTHI 1728, 10 &#x00B1; 2 PMNs entered the FOV within 10 min with planktonically grown, 22 &#x00B1; 2 with NBfA, and 31 &#x00B1; 1 with &#x03B1;-DNABII NRel. Again, these latter two values were statistically significant compared to planktonic (<italic>p</italic> = 0.003, <italic>p</italic> = 0.0002, respectively) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec id="S3.SS4">
<title>Lag phase of &#x03B1;-DNABII NTHI NRel was not responsible for the observed differences in PMN activity amongst the three bacterial populations</title>
<p>We recently reported that &#x03B1;-DNABII NTHI NRel are in lag phase as evidenced by their significantly upregulated expression of three genes canonically associated with this phase of bacterial growth (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>). As such, we wondered if perhaps characteristics of NTHI in this particular stage of growth might have played a role in the observed differences in relative PMN activity with this population of NTHI. To test this hypothesis, we recapitulated our timelapse microscopy assay and assessed relative PMN activity when incubated with mid-log phase planktonically grown NTHI 86-028NP or when incubated with lag phase planktonically grown NTHI 86-028NP. We observed no differences in PMN uptake or NETosis activity (<xref ref-type="fig" rid="F3">Figure 3A</xref>), nor was there a difference in the average number of additional PMNs that migrated into the FOV (<xref ref-type="fig" rid="F3">Figure 3B</xref>). These findings suggested that it was not only that &#x03B1;-DNABII NTHI NRel were specifically in lag phase which stimulated the greatest observed PMN activity.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Lag phase of &#x03B1;-DNABII NTHI NRel was not responsible for the observed relative differences in PMN activity amongst the three populations of NTHI tested. As &#x03B1;-DNABII NTHI NRel exhibit significant upregulation of genes canonically indicative of lag phase bacterial growth, we wondered if PMN detection of lag phase alone was an inducer of greater PMN influx when incubated with &#x03B1;-DNABII NTHI NRel. These data showed no difference in relative PMN activity <bold>(A)</bold> or influx <bold>(B)</bold> when PMNs were incubated with NTHI 86-028NP grown planktonically to mid-log phase versus to lag phase, which indicated that lag phase of growth alone was not responsible for the significantly greater influx of PMNs seen with &#x03B1;-DNABII NTHI NRel. Results represent the average &#x00B1; SEM of four independently run assays.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1728903-g003.tif">
<alt-text content-type="machine-generated">Representative images of PMN activity when incubated with log or lag phase grown planktonic NTHI. These data showed no difference in relative PMN activity (uptake or NETosis) (A) or influx (B) when PMNs were incubated with NTHI 86-028NP grown planktonically to mid-log phase versus to lag phase, which indicated that lag phase of growth alone was not responsible for the significantly greater influx of PMNs seen with &#x03B1;-DNABII NTHI NRel.</alt-text>
</graphic>
</fig>
</sec>
<sec id="S3.SS5">
<title>Relative differences in concentration of either NTHI endotoxin or DNA within supernatants in which NTHI populations were suspended when incubated with PMNs was also not responsible for the observed differences in relative PMN activity</title>
<p>We next wondered whether either PMN uptake and NETosis activities, or the differences observed in terms of movement of additional PMNs into the FOV when PMNs were specifically incubated with &#x03B1;-DNABII NTHI NRel, might be due to differences in relative amounts of either bacterial endotoxin or DNA within preparations of the three NTHI populations. Therefore, we assayed for both of these NTHI-associated pathogen-associated molecular patterns (PAMPs) within the fluids in which the PMNs had been exposed, as each has been shown to induce PMN NETosis, as reported by <xref ref-type="bibr" rid="B23">Juneau et al. (2011)</xref>. When we assessed relative levels of endotoxin, we found an average concentration of approximately 30&#x2013;40 endotoxin units/mL within each of the planktonic, NBfA, and &#x03B1;-DNABII NTHI NRel populations for all three tested NTHI isolates which suggested that differences in relative endotoxin concentration were not responsible for notable differences observed in PMN activity (<xref ref-type="fig" rid="F4">Figure 4A</xref>). We further determined the relative eDNA levels within the three population preparations for the three tested NTHI strains and found an average concentration of 0.3 ng DNA/&#x03BC;L in each (<xref ref-type="fig" rid="F4">Figure 4B</xref>), which suggested that relative eDNA concentration was also not responsible for differences in observed PMN activity.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Differences in relative endotoxin or DNA levels were not responsible for the observed differences in relative PMN activity amongst the three tested NTHI populations. Regardless of NTHI strain or population assessed, there was no difference in quantified concentration of either bacterial endotoxin <bold>(A)</bold> or extracellular DNA (eDNA) <bold>(B)</bold> within bacterial cell-free fluids that contained washed and dual-fluorescently labeled planktonic, NBfA, or &#x03B1;-DNABII NTHI NRel, which suggested that neither endotoxin nor eDNA present within the fluids that had contained the bacterial populations when incubated with human PMNs were responsible for the observed significantly increased PMN influx when co-cultured with &#x03B1;-DNABII NTHI NRel. Endotoxin and eDNA results represent the average &#x00B1; SEM of three independently run assays.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1728903-g004.tif">
<alt-text content-type="machine-generated">Bar graphs that assessed levels of endotoxin (A) or extracellular DNA (B) within bacterial cell-free fluids that contained washed &#x0026; dual-fluorescently labeled planktonic, NBfA, or &#x03B1;-DNABII NTHI NRel. Levels of endotoxin and eDNA were all similar and showed no difference between NTHI strains or bacterial populations which suggested that neither endotoxin nor eDNA present within the fluids that had contained the bacterial populations when incubated with human PMNs were responsible for the observed significantly increased PMN influx when co-cultured with &#x03B1;-DNABII NTHI NRel. Endotoxin and eDNA results represent the average &#x00B1; SEM of three independently run assays.</alt-text>
</graphic>
</fig>
</sec>
<sec id="S3.SS6">
<title>The chemokine IL-8 was likely responsible for notable relative differences in migration of additional PMNs into the FOV when PMNs were incubated with &#x03B1;-DNABII NTHI NRel</title>
<p>We next considered whether the PMNs themselves might be signaling for the observed migration of additional PMNs into the FOV when they were incubated with &#x03B1;-DNABII NTHI NRel. To test this hypothesis, we assessed the media in which PMNs and NTHI populations were incubated for the presence of an array of human cytokines or chemokines after 10 min of co-incubation. We found no notable differences or trends in levels of IL-12p70, TNF, IL-10, or IL-6, regardless of the NTHI strain or population (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>). We also assessed levels of additional cytokines known to be both pro-inflammatory and neutrophil recruiters or activators: IL-1&#x03B1;, IL-1&#x03B2;, IFN-&#x03B3;, and IFN-&#x03B1; (<xref ref-type="bibr" rid="B8">Chan et al., 2021</xref>). We observed increased levels of these latter cytokines, however, there were no observed trends in relative concentrations of these additional cytokines amongst the three NTHI populations of any of the three NTHI strains (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>). In contrast, levels of IL-8 were significantly increased in cultures of PMNs incubated with NBfA (average of 2.0&#x2013;3.5 pg IL-8/mL) relative to those incubated with planktonic NTHI (average of 1.0&#x2013;2.0 pg IL-8/mL), regardless of the NTHI strain assessed (<italic>p</italic> &#x003C; 0.05&#x2013;0.001) (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>). These results helped to validate our earlier timelapse microscopy-based observations in which we reported that significantly more PMNs entered the FOV when incubated with NBfA relative to those incubated with planktonically grown NTHI of all three strains assessed (see <xref ref-type="table" rid="T1">Table 1</xref>). Further, levels of IL-8 were also significantly increased and, in fact the greatest overall, when PMNs were incubated with &#x03B1;-DNABII NTHI NRel (average of 2.5&#x2013;4.0 pg IL-8/mL) relative to those incubated with planktonic NTHI (<italic>p</italic> &#x003C; 0.01&#x2013;0.0001), regardless of the NTHI strain, which also aligned well with our microscopy and quantification of additional PMNs that migrated into the FOV datasets. Further, significantly more PMNs entered the FOV when incubated with &#x03B1;-DNABII NTHI 86-028NP or 1728 NRel relative to when incubated with NBfA of either strain (<italic>p</italic> &#x003C; 0.01 and 0.05, respectively) (<xref ref-type="fig" rid="F5">Figure 5A&#x2013;C</xref>). We did not observe similar significant differences in IL-8 levels between &#x03B1;-DNABII NTHI 1128 NRel and NBfA (<italic>p</italic> = 0.36) (<xref ref-type="fig" rid="F5">Figure 5B</xref>), which was similarly corroborated by our video microscopy data and quantification of additional migrated PMNs (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>IL-8 was likely responsible for notable relative differences in migration of additional PMNs into the FOV when PMNs were incubated with &#x03B1;-DNABII NTHI NRel. Relative levels of human cytokines/chemokines produced by PMNs when incubated with planktonic, NBfA, or &#x03B1;-DNABII NTHI NRel were determined. Within 10 min of co-culture, levels of PMN-produced IL-8 were significantly increased when incubated with NBfA relative to planktonically grown NTHI for each of the 3 clinical NTHI isolates, 86-028NP <bold>(A)</bold>, 1128 <bold>(B)</bold>, or 1728 <bold>(C)</bold>. For NTHI strains 86-028NP <bold>(A)</bold> and 1728 <bold>(C)</bold>, the amount of IL-8 produced by PMNs incubated with &#x03B1;-DNABII NTHI NRel was also significantly greater compared to that when incubated with NBfA, results that were corroborated by microscopy and PMN migration datasets. However, regardless of NTHI strain tested, we consistently observed the greatest and most significantly increased levels of IL-8 produced by PMNs incubated with &#x03B1;-DNABII NTHI NRel relative to those incubated with planktonic NTHI. We observed no significant differences or trends for other assessed cytokines/chemokines. Increased levels of IL-8, a potent PMN-attracting chemokine, by PMNs exposed to &#x03B1;-DNABII NTHI NRel likely explains the observed and significant increase in average number of PMNs that entered the field of view in our microscopy assays. All results represent the average &#x00B1; SEM of three independently run assays and statistical significance was determined via independent ordinary one-way ANOVAs. &#x002A;<italic>p</italic> &#x2264; 0.05, &#x002A;&#x002A;<italic>p</italic> &#x2264; 0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x2264; 0.001, and &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x2264; 0.0001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1728903-g005.tif">
<alt-text content-type="machine-generated">A series of bar graphs that assessed levels of human cytokines/chemokines secreted by PMNs in the presence of planktonic, NBfA, or &#x03B1;-DNABII NRel NTHI 86-208NP (A), 1128 (B), or 1728 (C). When incubated with each strain, PMNs secreted no or low levels of cytokines IL-12p70, TNF, IL-10, IL-6, IL-1&#x03B1;, IL-1&#x03B2;, IFN-&#x03B3;, or IFN-&#x03B1;, with no trends observable. However, PMN secretion of IL-8 was significantly increased when incubated with &#x03B1;-DNABII NRel NTHI relative to when incubated with planktonic or NBfA NTHI, regardless of bacterial strain.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>There is an urgent need for highly effective novel therapeutics, and ideally preventative strategies, for better management of chronic and recurrent biofilm-related diseases, as they are notoriously recalcitrant to clearance by antibiotics and effectors of the host immune system (<xref ref-type="bibr" rid="B54">Roilides et al., 2015</xref>; <xref ref-type="bibr" rid="B20">Grooters et al., 2024</xref>). One strategy to address these issues is to actively release biofilm-resident bacteria from their protective matrix such that they are now more readily accessible to both conventional antibiotics and immune effectors. To that end, we have focused on structurally essential proteins within the biofilm matrix, the bacterial DNABII proteins (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B48">2020</xref>; <xref ref-type="bibr" rid="B53">Rogers et al., 2022</xref>), which bind at the vertices of crossed-strands of extracellular DNA to stabilize the biofilm matrix (<xref ref-type="bibr" rid="B18">Goodman et al., 2011</xref>). When a monoclonal antibody directed against the immunoprotective DNA-binding &#x201C;tips&#x201D; of a DNABII protein is incubated with a bacterial biofilm formed individually by any of 24 distinct genera, each member of the ESKAPEE pathogens, or with polymicrobial biofilms, the biofilm collapses within minutes (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B47">2019</xref>; <xref ref-type="bibr" rid="B24">Jurcisek et al., 2022</xref>; <xref ref-type="bibr" rid="B30">Kurbatfinski et al., 2022</xref>, <xref ref-type="bibr" rid="B31">Kurbatfinski et al., 2023a</xref>,<xref ref-type="bibr" rid="B32">b</xref>; <xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>; <xref ref-type="bibr" rid="B52">Rhodes et al., 2024</xref>). These rapidly released formerly biofilm-resident pathogens are now significantly more susceptible to killing by antibiotics and antimicrobial peptides <italic>in vitro</italic> (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>; <xref ref-type="bibr" rid="B24">Jurcisek et al., 2022</xref>; <xref ref-type="bibr" rid="B30">Kurbatfinski et al., 2022</xref>, <xref ref-type="bibr" rid="B31">Kurbatfinski et al., 2023a</xref>,<xref ref-type="bibr" rid="B32">b</xref>; <xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>; <xref ref-type="bibr" rid="B52">Rhodes et al., 2024</xref>).</p>
<p>Further, we&#x2019;ve now demonstrated pre-clinical efficacy in four models of biofilm infections after treatment with this DNABII-directed monoclonal (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B46">2021</xref>; <xref ref-type="bibr" rid="B16">Freire et al., 2017</xref>; <xref ref-type="bibr" rid="B25">Jurcisek et al., 2025</xref>). Importantly, these outcomes were achieved without use of any co-delivered antibiotics, which highlighted the primary role of innate immune effectors. We found that in either the rat oral cavity, chinchilla middle ear or mouse lungs the mucosa appeared to rapidly return to homeostatic states in &#x03B1;-DNABII-treated animals (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B46">2021</xref>; <xref ref-type="bibr" rid="B16">Freire et al., 2017</xref>; <xref ref-type="bibr" rid="B25">Jurcisek et al., 2025</xref>). When we tested the role of innate immune effectors <italic>in vitro</italic>, we indeed found support for this hypothesis, as NTHI newly released from biofilms via &#x03B1;-DNABII were significantly more susceptible to killing by antimicrobial peptides and human PMNs (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>; <xref ref-type="bibr" rid="B33">Kurbatfinski et al., 2025</xref>). However, we did not yet know the full complement of differences in overall PMN activity when PMNs encountered newly released NTHI, as they would have in the pre-clinical efficacy models described above.</p>
<p>Data presented here revealed that PMN activity was indeed notably different when exposed to newly released NTHI. Whereas PMNs demonstrated uptake and NETosis with all tested populations of NTHI, they were nonetheless able to discriminate between NTHI grown planktonically <italic>versus</italic> those present in fluid above a biofilm <italic>versus</italic> those rapidly released from biofilm residence via the DNABII-targeted monoclonal. Further, while the overall trends of activity amongst the tested bacterial populations were highly similar for all three clinical isolates of NTHI assessed herein, there was nonetheless some slight variability in PMN activity which is likely due to vast heterogeneity of NTHI, as has been previously documented for these isolates both <italic>in vitro</italic> as well as when characterized in pre-clinical models (<xref ref-type="bibr" rid="B2">Bakaletz et al., 1988</xref>; <xref ref-type="bibr" rid="B60">Sirakova et al., 1994</xref>; <xref ref-type="bibr" rid="B10">DeMaria et al., 1996</xref>; <xref ref-type="bibr" rid="B41">Miyamoto and Bakaletz, 1996</xref>; <xref ref-type="bibr" rid="B1">Bakaletz et al., 1997</xref>; <xref ref-type="bibr" rid="B45">Novotny and Bakaletz, 2003</xref>). Regardless of any slight differences observed amongst NTHI strains within data obtained via timelapse microscopy, flow cytometry, and chemokine analysis as presented here, we nonetheless observed highly similar overall patterns when PMNs were incubated with planktonically grown NTHI versus those recovered from the fluids above a biofilm or those newly released from biofilm residence by the action of &#x03B1;-DNABII, regardless of the strain assessed. It should be noted that whereas we did test three clinical isolates of NTHI, each with their own known inherent heterogeneity in the work presented here, these are nonetheless all isolates recovered from children with chronic otitis media which is therein an acknowledged potential limitation.</p>
<p>Interestingly, it is important to note that PMN activity with NBfA NTHI tended to be more similar to that with &#x03B1;-DNABII NTHI NRel than it was to PMN activity with NTHI grown planktonically in all ways assessed here. The NBfA population is likely an isogenic but heterogeneous mix of phenotypically variable cells (<xref ref-type="bibr" rid="B61">Spratt and Lane, 2022</xref>) that includes both NTHI that are simply growing in the fluids above the biofilm as well as those that have come off the biofilm as a result of natural biofilm remodeling (<xref ref-type="bibr" rid="B28">Kostakioti et al., 2013</xref>). Given that bacteria growing planktonically in nutrient-rich media do not exist in nature, we used the NBfA population to attempt to more closely represent those bacteria found in a disease site that are within fluids in close proximity to the pathogenic biofilm but not resident within it (e.g., synovial joint fluids, middle ear effusions, lung aspirates, etc.). The notable PMN activity we report here with the NBfA population was intriguing as this is likely a very heterogeneous mix of NTHI that accumulated in the medium that overlayed the biofilm in the 2 h incubation period described here. This population is believed to be a mix of bacteria which have perhaps come off the biofilm due to natural remodeling, include non-adherent bacteria that were not washed off prior to the 2 h incubation period and even those that may have divided during planktonic growth in this period of time. That PMNs were quite active with the NBfA population may help explain why fluids recovered from clinical sites of bacterial infection, wherein biofilms are implicated, are often culture negative despite the continued presence of a pathogenic biofilm in the same site. Whereas these clinical fluids may contain viable but not culturable bacteria, this sterile status may also be reflective of enhanced PMN activity against these NBfA-like bacteria, as well as that of other immune effectors, that are otherwise ineffective when these disease-associated pathogens are resident within the biofilm (<xref ref-type="bibr" rid="B17">Fux et al., 2006</xref>; <xref ref-type="bibr" rid="B58">Schulz et al., 2021</xref>).</p>
<p>That healthy human PMNs were able to distinguish amongst the three tested populations of NTHI was not explained by relative differences in levels of endotoxin (i.e., lipooligosaccharide), eDNA, or the characteristic lag phase of newly released NTHI (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>). There was, however, a significant difference in levels of PMN-produced interleukin (IL)-8 detected when human PMNs were incubated with either NBfA or NRel compared to planktonic bacteria. IL-8 is a potent PMN-recruiting chemokine with additional important roles in activation of PMNs to release granule contents, generate superoxide, and increase expression of adhesion molecules (<xref ref-type="bibr" rid="B4">Bickel, 1993</xref>; <xref ref-type="bibr" rid="B39">Matsushima et al., 2022</xref>). Intra-PMN signaling via IL-8 when incubated with newly released NTHI is another likely mechanism by which this important innate immune effector contributed to the outcomes we reported to-date in four pre-clinical models of biofilm disease resolution wherein we targeted the DNABII proteins (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>; <xref ref-type="bibr" rid="B16">Freire et al., 2017</xref>; <xref ref-type="bibr" rid="B46">Novotny et al., 2021</xref>; <xref ref-type="bibr" rid="B25">Jurcisek et al., 2025</xref>). It is important to note that whereas both planktonic and biofilm-resident NTHI have mechanisms to evade PMN killing (<xref ref-type="bibr" rid="B22">Hong et al., 2009</xref>; <xref ref-type="bibr" rid="B23">Juneau et al., 2011</xref>), these two populations of NTHI have notably different phenotypes from those that have been freshly dispersed from bacterial biofilms via a number of mechanisms as has been reported for multiple pathogens (<xref ref-type="bibr" rid="B55">Rollet et al., 2009</xref>; <xref ref-type="bibr" rid="B9">Chua et al., 2014</xref>; <xref ref-type="bibr" rid="B3">Barraud et al., 2015</xref>; <xref ref-type="bibr" rid="B21">Guilhen et al., 2016</xref>; <xref ref-type="bibr" rid="B63">Uppuluri et al., 2018</xref>; <xref ref-type="bibr" rid="B26">Kalia and Sauer, 2024</xref>; <xref ref-type="bibr" rid="B57">Sahu et al., 2025</xref>). Further, both we and others have shown that this distinct phenotype and transcriptome is evident within minutes of dispersal from a biofilm (<xref ref-type="bibr" rid="B42">Mokrzan et al., 2020</xref>; <xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>; <xref ref-type="bibr" rid="B26">Kalia and Sauer, 2024</xref>).</p>
<p>Thereby, we posit that the enhanced activity we report here when human PMNs encountered NRel populations of NTHI, as well as earlier (<xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>), and in pre-clinical models (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B46">2021</xref>; <xref ref-type="bibr" rid="B16">Freire et al., 2017</xref>; <xref ref-type="bibr" rid="B25">Jurcisek et al., 2025</xref>), is likely due to the specific manner of active release mediated by the anti-DNABII monoclonal antibody combined with the distinct phenotype of this newly released population. Intriguingly, <italic>Pseudomonas aeruginosa</italic> freshly dispersed from a biofilm as induced via the action of nitric oxide and glutamate was shown capable of significantly evading engulfment by macrophages (<xref ref-type="bibr" rid="B26">Kalia and Sauer, 2024</xref>), and the potential for increased virulence has been reported for other bacteria actively dispersed from a biofilm via a programmed pathway (<xref ref-type="bibr" rid="B15">Fleming and Rumbaugh, 2018</xref>; <xref ref-type="bibr" rid="B44">Murray et al., 2025</xref>). Taken together, it appears likely that there is yet another aspect of phenotypic variability between freshly dispersed bacteria (e.g., as induced by either native or active induction to mediate dispersal via a programmed pathway) <italic>versus</italic> that observed in newly released bacteria (e.g., as mediated by rapid collapse of the biofilm as described here), the latter of which does not allow for bacterial adaptation prior to exit from the protective biofilm. Nonetheless, whereas fresh actively dispersed bacterial cells and those newly but passively released (due to an external disturbance that physically or enzymatically destroys the biofilm matrix or detaches it) do share some phenotypic similarities (<xref ref-type="bibr" rid="B44">Murray et al., 2025</xref>), importantly no evidence of enhanced virulence has been observed for newly released bacteria (<xref ref-type="bibr" rid="B49">Novotny et al., 2016</xref>, <xref ref-type="bibr" rid="B46">2021</xref>; <xref ref-type="bibr" rid="B16">Freire et al., 2017</xref>; <xref ref-type="bibr" rid="B51">Redman et al., 2021</xref>; <xref ref-type="bibr" rid="B25">Jurcisek et al., 2025</xref>). What we do not yet know is whether any of the described phenotypes are specific to rapid release by anti-DNABII or if other forms of rapid release will induce the same outcome, however, this is an active area of investigation for our laboratories.</p>
<p>Collectively, new data described here provide additional mechanistic insights as to how NTHI newly released from biofilms via the DNABII-targeted monoclonal are likely rapidly and effectively cleared <italic>in vivo</italic>. It is worth noting that treatment with this targeted monoclonal may also benefit from either carefully titrated delivery and/or supplemental antibiotic treatment, depending on the host&#x2019;s immune status, nature of the disease, and location of the infection, in order to ensure that release of biofilm-resident bacteria does not produce an overwhelming inflammatory response or wherein released bacteria could travel to other parts of the body and/or potentially cause septicemia (<xref ref-type="bibr" rid="B27">Koo et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Fleming and Rumbaugh, 2018</xref>). However, we nonetheless believe this monoclonal antibody to be a potentially widely applicable therapeutic option across a range of diverse diseases given that it targets universal and structurally essential proteins of the biofilm matrix as evidenced by data which shows that it can rapidly and significantly disrupt biofilms formed by 24 diverse genera of pathogens to date (<xref ref-type="bibr" rid="B43">Mokrzan et al., 2018</xref>, <xref ref-type="bibr" rid="B42">2020</xref>; <xref ref-type="bibr" rid="B30">Kurbatfinski et al., 2022</xref>, <xref ref-type="bibr" rid="B31">Kurbatfinski et al., 2023a</xref>,<xref ref-type="bibr" rid="B32">b</xref>; <xref ref-type="bibr" rid="B65">Wilbanks et al., 2023</xref>). This specifically targeted monoclonal is currently in clinical trials [NCT05629741; NCT06159725] wherein we aspire for a positive outcome as a result of similar rapid eradication of pathogenic biofilms with clearance of bacteria once released from their protective biofilm matrix. In a world where antibiotic resistance and immune evasion lend numerous advantages to bacteria resident within pathogenic biofilms, it is our hope that this monoclonal antibody-based approach, designed to be pathogen-agnostic, may provide a widely effective and powerful therapeutic option.</p>
</sec>
</body>
<back>
<sec id="S5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in this study are included in this article/<xref ref-type="supplementary-material" rid="DS1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="S6" sec-type="author-contributions">
<title>Author contributions</title>
<p>KW: Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. JF: Investigation, Methodology, Writing &#x2013; review &#x0026; editing. SG: Conceptualization, Funding acquisition, Writing &#x2013; review &#x0026; editing. LB: Conceptualization, Funding acquisition, Methodology, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Jennifer Neelans for excellent assistance with manuscript preparation and the Microscopy Core at Nationwide Children&#x2019;s Hospital for providing microscopy resources and support. We also thank the Flow Cytometry Core at Nationwide Children&#x2019;s Hospital for providing flow cytometry resources and assistance. Finally, we extend gratitude to those individuals who donated blood through Nationwide Children&#x2019;s Hospital&#x2019;s Abigail Wexner Research Institute Blood Donor Service. The corresponding author had full access to all of the data and had the final responsibility to submit for publication.</p>
</ack>
<sec id="S8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>LB and SG are inventors of technology related to the DNABII-directed approach. Nationwide Children&#x2019;s Hospital (NCH) has licensed the rights to this technology to Clarametyx Biosciences, Inc., NCH has rights to future royalty and/or license fees and payments under the licensing agreement. LB and SG are consultants, scientific co-founders, equity holders, and Scientific Advisory Board members of Clarametyx Biosciences, Inc.,</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="S10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2025.1728903/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2025.1728903/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="DS1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Video_1.mp4" id="VS1" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_2.mp4" id="VS2" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_3.mp4" id="VS3" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_4.mp4" id="VS4" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_5.mp4" id="VS5" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_6.mp4" id="VS6" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_7.mp4" id="VS7" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_8.mp4" id="VS8" mimetype="video/mp4"/>
<supplementary-material xlink:href="Video_9.mp4" id="VS9" mimetype="video/mp4"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name> <name><surname>Leake</surname> <given-names>E. R.</given-names></name> <name><surname>Billy</surname> <given-names>J. M.</given-names></name> <name><surname>Kaumaya</surname> <given-names>P. T.</given-names></name></person-group> (<year>1997</year>). <article-title>Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable <italic>Haemophilus influenzae</italic> in the chinchilla.</article-title> <source><italic>Vaccine</italic></source> <volume>15</volume> <fpage>955</fpage>&#x2013;<lpage>961</lpage>. <pub-id pub-id-type="doi">10.1016/s0264-410x(96)00298-8</pub-id> <pub-id pub-id-type="pmid">9261941</pub-id></mixed-citation></ref>
<ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name> <name><surname>Tallan</surname> <given-names>B. M.</given-names></name> <name><surname>Hoepf</surname> <given-names>T.</given-names></name> <name><surname>DeMaria</surname> <given-names>T. F.</given-names></name> <name><surname>Birck</surname> <given-names>H. G.</given-names></name> <name><surname>Lim</surname> <given-names>D. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Frequency of fimbriation of nontypable <italic>Haemophilus influenzae</italic> and its ability to adhere to chinchilla and human respiratory epithelium.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>56</volume> <fpage>331</fpage>&#x2013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1128/iai.56.2.331-335.1988</pub-id> <pub-id pub-id-type="pmid">2892792</pub-id></mixed-citation></ref>
<ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barraud</surname> <given-names>N.</given-names></name> <name><surname>Kjelleberg</surname> <given-names>S.</given-names></name> <name><surname>Rice</surname> <given-names>S. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Dispersal from microbial biofilms.</article-title> <source><italic>Microbiol. Spectr.</italic></source> <volume>3</volume>:<fpage>MB-0015-2014</fpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.MB-0015-2014</pub-id>. <pub-id pub-id-type="pmid">27337281</pub-id></mixed-citation></ref>
<ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickel</surname> <given-names>M.</given-names></name></person-group> (<year>1993</year>). <article-title>The role of interleukin-8 in inflammation and mechanisms of regulation.</article-title> <source><italic>J. Periodontol.</italic></source> <volume>64</volume>(<issue>5 Suppl.</issue>), <fpage>456</fpage>&#x2013;<lpage>460</lpage>.</mixed-citation></ref>
<ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boisvert</surname> <given-names>A. A.</given-names></name> <name><surname>Cheng</surname> <given-names>M. P.</given-names></name> <name><surname>Sheppard</surname> <given-names>D. C.</given-names></name> <name><surname>Nguyen</surname> <given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Microbial biofilms in pulmonary and critical care diseases.</article-title> <source><italic>Ann. Am. Thorac Soc.</italic></source> <volume>13</volume> <fpage>1615</fpage>&#x2013;<lpage>1623</lpage>. <pub-id pub-id-type="doi">10.1513/AnnalsATS.201603-194FR</pub-id> <pub-id pub-id-type="pmid">27348071</pub-id></mixed-citation></ref>
<ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzzo</surname> <given-names>J. R.</given-names></name> <name><surname>Devaraj</surname> <given-names>A.</given-names></name> <name><surname>Gloag</surname> <given-names>E. S.</given-names></name> <name><surname>Jurcisek</surname> <given-names>J. A.</given-names></name> <name><surname>Robledo-Avila</surname> <given-names>F.</given-names></name> <name><surname>Kesler</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Z-form extracellular DNA is a structural component of the bacterial biofilm matrix.</article-title> <source><italic>Cell</italic></source> <volume>184</volume> <fpage>5740</fpage>&#x2013;<lpage>5758 e17</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.10.010</pub-id> <pub-id pub-id-type="pmid">34735796</pub-id></mixed-citation></ref>
<ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>J. R.</given-names></name> <name><surname>Cherny</surname> <given-names>K. E.</given-names></name> <name><surname>Sauer</surname> <given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Susceptibility of <italic>Pseudomonas aeruginosa</italic> dispersed cells to antimicrobial agents is dependent on the dispersion cue and class of the antimicrobial agent used.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>61</volume>:<fpage>e00846-17</fpage>. <pub-id pub-id-type="doi">10.1128/aac.00846-17</pub-id> <pub-id pub-id-type="pmid">28971863</pub-id></mixed-citation></ref>
<ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>L.</given-names></name> <name><surname>Karimi</surname> <given-names>N.</given-names></name> <name><surname>Morovati</surname> <given-names>S.</given-names></name> <name><surname>Alizadeh</surname> <given-names>K.</given-names></name> <name><surname>Kakish</surname> <given-names>J. E.</given-names></name> <name><surname>Vanderkamp</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>The roles of neutrophils in cytokine storms.</article-title> <source><italic>Viruses</italic></source> <volume>13</volume>:<fpage>2318</fpage>. <pub-id pub-id-type="doi">10.3390/v13112318</pub-id> <pub-id pub-id-type="pmid">34835125</pub-id></mixed-citation></ref>
<ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname> <given-names>S. L.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Yam</surname> <given-names>J. K.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Vejborg</surname> <given-names>R. M.</given-names></name> <name><surname>Tan</surname> <given-names>B. G.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>5</volume>:<fpage>4462</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms5462</pub-id> <pub-id pub-id-type="pmid">25042103</pub-id></mixed-citation></ref>
<ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeMaria</surname> <given-names>T. F.</given-names></name> <name><surname>Murwin</surname> <given-names>D. M.</given-names></name> <name><surname>Leake</surname> <given-names>E. R.</given-names></name></person-group> (<year>1996</year>). <article-title>Immunization with outer membrane protein P6 from nontypeable <italic>Haemophilus influenzae</italic> induces bactericidal antibody and affords protection in the chinchilla model of otitis media.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>64</volume> <fpage>5187</fpage>&#x2013;<lpage>5192</lpage>. <pub-id pub-id-type="doi">10.1128/iai.64.12.5187-5192.1996</pub-id> <pub-id pub-id-type="pmid">8945564</pub-id></mixed-citation></ref>
<ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devaraj</surname> <given-names>A.</given-names></name> <name><surname>Buzzo</surname> <given-names>J.</given-names></name> <name><surname>Rocco</surname> <given-names>C. J.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name></person-group> (<year>2018</year>). <article-title>The DNABII family of proteins is comprised of the only nucleoid associated proteins required for nontypeable <italic>Haemophilus influenzae</italic> biofilm structure.</article-title> <source><italic>Microbiologyopen</italic></source> <volume>7</volume>:<fpage>e00563</fpage>. <pub-id pub-id-type="doi">10.1002/mbo3.563</pub-id> <pub-id pub-id-type="pmid">29230970</pub-id></mixed-citation></ref>
<ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname> <given-names>D.</given-names></name> <name><surname>Nagaraja</surname> <given-names>V.</given-names></name> <name><surname>Ramakumar</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Structural and evolutionary analyses reveal determinants of DNA binding specificities of nucleoid-associated proteins HU and IHF.</article-title> <source><italic>Mol. Phylogenet. Evol.</italic></source> <volume>107</volume> <fpage>356</fpage>&#x2013;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/j.ympev.2016.11.014</pub-id> <pub-id pub-id-type="pmid">27894997</pub-id></mixed-citation></ref>
<ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Domenico</surname> <given-names>E. G.</given-names></name> <name><surname>Oliva</surname> <given-names>A.</given-names></name> <name><surname>Guembe</surname> <given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>The current knowledge on the pathogenesis of tissue and medical device-related biofilm infections.</article-title> <source><italic>Microorganisms</italic></source> <volume>10</volume>:<fpage>1259</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms10071259</pub-id> <pub-id pub-id-type="pmid">35888978</pub-id></mixed-citation></ref>
<ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duell</surname> <given-names>B. L.</given-names></name> <name><surname>Su</surname> <given-names>Y. C.</given-names></name> <name><surname>Riesbeck</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Host-pathogen interactions of nontypeable <italic>Haemophilus influenzae</italic>: From commensal to pathogen.</article-title> <source><italic>FEBS Lett.</italic></source> <volume>590</volume> <fpage>3840</fpage>&#x2013;<lpage>3853</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12351</pub-id> <pub-id pub-id-type="pmid">27508518</pub-id></mixed-citation></ref>
<ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname> <given-names>D.</given-names></name> <name><surname>Rumbaugh</surname> <given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>The consequences of biofilm dispersal on the host.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>8</volume>:<fpage>10738</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-29121-2</pub-id> <pub-id pub-id-type="pmid">30013112</pub-id></mixed-citation></ref>
<ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname> <given-names>M. O.</given-names></name> <name><surname>Devaraj</surname> <given-names>A.</given-names></name> <name><surname>Young</surname> <given-names>A.</given-names></name> <name><surname>Navarro</surname> <given-names>J. B.</given-names></name> <name><surname>Downey</surname> <given-names>J. S.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>A bacterial-biofilm-induced oral osteolytic infection can be successfully treated by immuno-targeting an extracellular nucleoid-associated protein.</article-title> <source><italic>Mol. Oral Microbiol.</italic></source> <volume>32</volume> <fpage>74</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1111/omi.12155</pub-id> <pub-id pub-id-type="pmid">26931773</pub-id></mixed-citation></ref>
<ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fux</surname> <given-names>C. A.</given-names></name> <name><surname>Quigley</surname> <given-names>M.</given-names></name> <name><surname>Worel</surname> <given-names>A. M.</given-names></name> <name><surname>Post</surname> <given-names>C.</given-names></name> <name><surname>Zimmerli</surname> <given-names>S.</given-names></name> <name><surname>Ehrlich</surname> <given-names>G.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Biofilm-related infections of cerebrospinal fluid shunts.</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>12</volume> <fpage>331</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01361.x</pub-id> <pub-id pub-id-type="pmid">16524409</pub-id></mixed-citation></ref>
<ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Obergfell</surname> <given-names>K. P.</given-names></name> <name><surname>Jurcisek</surname> <given-names>J. A.</given-names></name> <name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Downey</surname> <given-names>J. S.</given-names></name> <name><surname>Ayala</surname> <given-names>E. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins.</article-title> <source><italic>Mucosal Immunol.</italic></source> <volume>4</volume> <fpage>625</fpage>&#x2013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2011.27</pub-id> <pub-id pub-id-type="pmid">21716265</pub-id></mixed-citation></ref>
<ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwine</surname> <given-names>J.</given-names></name> <name><surname>Gil</surname> <given-names>J.</given-names></name> <name><surname>Doiron</surname> <given-names>A.</given-names></name> <name><surname>Valdes</surname> <given-names>J.</given-names></name> <name><surname>Solis</surname> <given-names>M.</given-names></name> <name><surname>Higa</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>9</volume>:<fpage>3763</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-40378-z</pub-id> <pub-id pub-id-type="pmid">30842579</pub-id></mixed-citation></ref>
<ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grooters</surname> <given-names>K. E.</given-names></name> <name><surname>Ku</surname> <given-names>J. C.</given-names></name> <name><surname>Richter</surname> <given-names>D. M.</given-names></name> <name><surname>Krinock</surname> <given-names>M. J.</given-names></name> <name><surname>Minor</surname> <given-names>A.</given-names></name> <name><surname>Li</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Strategies for combating antibiotic resistance in bacterial biofilms.</article-title> <source><italic>Front. Cell Infect. Microbiol.</italic></source> <volume>14</volume>:<fpage>1352273</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2024.1352273</pub-id> <pub-id pub-id-type="pmid">38322672</pub-id></mixed-citation></ref>
<ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilhen</surname> <given-names>C.</given-names></name> <name><surname>Charbonnel</surname> <given-names>N.</given-names></name> <name><surname>Parisot</surname> <given-names>N.</given-names></name> <name><surname>Gueguen</surname> <given-names>N.</given-names></name> <name><surname>Iltis</surname> <given-names>A.</given-names></name> <name><surname>Forestier</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Transcriptional profiling of <italic>Klebsiella pneumoniae</italic> defines signatures for planktonic, sessile and biofilm-dispersed cells.</article-title> <source><italic>BMC Genom.</italic></source> <volume>17</volume>:<fpage>237</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-016-2557-x</pub-id> <pub-id pub-id-type="pmid">26979871</pub-id></mixed-citation></ref>
<ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>W.</given-names></name> <name><surname>Juneau</surname> <given-names>R. A.</given-names></name> <name><surname>Pang</surname> <given-names>B.</given-names></name> <name><surname>Swords</surname> <given-names>W. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable <italic>Haemophilus influenzae</italic> persistence in the chinchilla model for otitis media.</article-title> <source><italic>J. Innate Immun.</italic></source> <volume>1</volume> <fpage>215</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1159/000205937</pub-id> <pub-id pub-id-type="pmid">20375579</pub-id></mixed-citation></ref>
<ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juneau</surname> <given-names>R. A.</given-names></name> <name><surname>Pang</surname> <given-names>B.</given-names></name> <name><surname>Weimer</surname> <given-names>K. E.</given-names></name> <name><surname>Armbruster</surname> <given-names>C. E.</given-names></name> <name><surname>Swords</surname> <given-names>W. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> initiates formation of neutrophil extracellular traps.</article-title> <source><italic>Infect Immun.</italic></source> <volume>79</volume> <fpage>431</fpage>&#x2013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00660-10</pub-id> <pub-id pub-id-type="pmid">20956567</pub-id></mixed-citation></ref>
<ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurcisek</surname> <given-names>J. A.</given-names></name> <name><surname>Hofer</surname> <given-names>L. K.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2022</year>). <article-title>Monoclonal antibodies that target extracellular DNABII proteins or the type IV pilus of nontypeable <italic>Haemophilus influenzae</italic> (NTHI) worked additively to disrupt 2-genera biofilms.</article-title> <source><italic>Biofilm</italic></source> <volume>4</volume>:<fpage>100096</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioflm.2022.100096</pub-id> <pub-id pub-id-type="pmid">36532267</pub-id></mixed-citation></ref>
<ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurcisek</surname> <given-names>J. A.</given-names></name> <name><surname>Kurbatfinski</surname> <given-names>N.</given-names></name> <name><surname>Wilbanks</surname> <given-names>K. Q.</given-names></name> <name><surname>Rhodes</surname> <given-names>J. D.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2025</year>). <article-title><italic>Mycobacterium abscessus</italic> biofilm cleared from murine lung by monoclonal antibody against bacterial DNABII proteins.</article-title> <source><italic>J. Cyst. Fibros</italic></source> <volume>24</volume> <fpage>374</fpage>&#x2013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcf.2025.01.013</pub-id> <pub-id pub-id-type="pmid">39919951</pub-id></mixed-citation></ref>
<ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname> <given-names>M.</given-names></name> <name><surname>Sauer</surname> <given-names>K.</given-names></name></person-group> (<year>2024</year>). <article-title>Distinct transcriptome and traits of freshly dispersed <italic>Pseudomonas aeruginosa</italic> cells.</article-title> <source><italic>mSphere</italic></source> <volume>9</volume>:<fpage>e0088424</fpage>. <pub-id pub-id-type="doi">10.1128/msphere.00884-24</pub-id> <pub-id pub-id-type="pmid">39601567</pub-id></mixed-citation></ref>
<ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>H.</given-names></name> <name><surname>Allan</surname> <given-names>R. N.</given-names></name> <name><surname>Howlin</surname> <given-names>R. P.</given-names></name> <name><surname>Stoodley</surname> <given-names>P.</given-names></name> <name><surname>Hall-Stoodley</surname> <given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Targeting microbial biofilms: Current and prospective therapeutic strategies.</article-title> <source><italic>Nat. Rev. Microbiol.</italic></source> <volume>15</volume> <fpage>740</fpage>&#x2013;<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2017.99</pub-id> <pub-id pub-id-type="pmid">28944770</pub-id></mixed-citation></ref>
<ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostakioti</surname> <given-names>M.</given-names></name> <name><surname>Hadjifrangiskou</surname> <given-names>M.</given-names></name> <name><surname>Hultgren</surname> <given-names>S. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Bacterial biofilms: Development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.</article-title> <source><italic>Cold Spring Harb. Perspect. Med.</italic></source> <volume>3</volume>:<fpage>a010306</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a010306</pub-id> <pub-id pub-id-type="pmid">23545571</pub-id></mixed-citation></ref>
<ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kragh</surname> <given-names>K. N.</given-names></name> <name><surname>Tolker-Nielsen</surname> <given-names>T.</given-names></name> <name><surname>Lichtenberg</surname> <given-names>M.</given-names></name></person-group> (<year>2023</year>). <article-title>The non-attached biofilm aggregate.</article-title> <source><italic>Commun. Biol.</italic></source> <volume>6</volume>:<fpage>898</fpage>. <pub-id pub-id-type="doi">10.1038/s42003-023-05281-4</pub-id> <pub-id pub-id-type="pmid">37658117</pub-id></mixed-citation></ref>
<ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurbatfinski</surname> <given-names>N.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2022</year>). <article-title>A humanized monoclonal antibody potentiates killing of diverse biofilm-forming respiratory tract pathogens by antibiotics.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>66</volume> <issue>e0187721</issue>. <pub-id pub-id-type="doi">10.1128/aac.01877-21</pub-id> <pub-id pub-id-type="pmid">35007137</pub-id></mixed-citation></ref>
<ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurbatfinski</surname> <given-names>N.</given-names></name> <name><surname>Hill</surname> <given-names>P. J.</given-names></name> <name><surname>Tobin</surname> <given-names>N.</given-names></name> <name><surname>Kramer</surname> <given-names>C. N.</given-names></name> <name><surname>Wickham</surname> <given-names>J.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name><etal/></person-group> (<year>2023a</year>). <article-title>Disruption of nontuberculous mycobacteria biofilms induces a highly vulnerable to antibiotic killing phenotype.</article-title> <source><italic>Biofilm</italic></source> <volume>6</volume>:<fpage>100166</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioflm.2023.100166</pub-id> <pub-id pub-id-type="pmid">38078059</pub-id></mixed-citation></ref>
<ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurbatfinski</surname> <given-names>N.</given-names></name> <name><surname>Kramer</surname> <given-names>C. N.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2023b</year>). <article-title>ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>14</volume>:<fpage>1202215</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2023.1202215</pub-id> <pub-id pub-id-type="pmid">37564292</pub-id></mixed-citation></ref>
<ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurbatfinski</surname> <given-names>N.</given-names></name> <name><surname>Jurscisek</surname> <given-names>J. A.</given-names></name> <name><surname>Wilbanks</surname> <given-names>K. Q.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2025</year>). <article-title>Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant <italic>Staphylococcus aureus</italic> and nontypeable <italic>Haemophilus influenzae</italic> isolates after disruption from biofilm residence.</article-title> <source><italic>Microbiol. Spectr.</italic></source> <volume>13</volume>:<fpage>e0306624</fpage>. <pub-id pub-id-type="doi">10.1128/spectrum.03066-24</pub-id> <pub-id pub-id-type="pmid">40530663</pub-id></mixed-citation></ref>
<ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>W. L.</given-names></name> <name><surname>Harrison</surname> <given-names>R. E.</given-names></name> <name><surname>Grinstein</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Phagocytosis by neutrophils.</article-title> <source><italic>Microbes Infect.</italic></source> <volume>5</volume> <fpage>1299</fpage>&#x2013;<lpage>1306</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2003.09.014</pub-id> <pub-id pub-id-type="pmid">14613773</pub-id></mixed-citation></ref>
<ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Petrova</surname> <given-names>O. E.</given-names></name> <name><surname>Su</surname> <given-names>S.</given-names></name> <name><surname>Lau</surname> <given-names>G. W.</given-names></name> <name><surname>Panmanee</surname> <given-names>W.</given-names></name> <name><surname>Na</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>PLoS Pathog</italic></source> <volume>10</volume>:<fpage>e1004168</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004168</pub-id> <pub-id pub-id-type="pmid">24901523</pub-id></mixed-citation></ref>
<ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname> <given-names>P. X.</given-names></name> <name><surname>Kubes</surname> <given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>The neutrophil&#x2019;s role during health and disease.</article-title> <source><italic>Physiol. Rev.</italic></source> <volume>99</volume> <fpage>1223</fpage>&#x2013;<lpage>1248</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00012.2018</pub-id> <pub-id pub-id-type="pmid">30758246</pub-id></mixed-citation></ref>
<ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname> <given-names>L. R.</given-names></name> <name><surname>Davidson</surname> <given-names>B. A.</given-names></name> <name><surname>Knight</surname> <given-names>P. R.</given-names></name> <name><surname>Hakansson</surname> <given-names>A. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Interkingdom signaling induces <italic>Streptococcus pneumoniae</italic> biofilm dispersion and transition from asymptomatic colonization to disease.</article-title> <source><italic>mBio</italic></source> <volume>4</volume>:<fpage>e0043813</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.00438-13</pub-id> <pub-id pub-id-type="pmid">23882016</pub-id></mixed-citation></ref>
<ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname> <given-names>K. M.</given-names></name> <name><surname>Munson</surname> <given-names>R. S.</given-names> <suffix>Jr.</suffix></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2003</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> gene expression induced <italic>in vivo</italic> in a chinchilla model of otitis media.</article-title> <source><italic>Infect Immun.</italic></source> <volume>71</volume> <fpage>3454</fpage>&#x2013;<lpage>3462</lpage>. <pub-id pub-id-type="doi">10.1128/iai.71.6.3454-3462.2003</pub-id> <pub-id pub-id-type="pmid">12761130</pub-id></mixed-citation></ref>
<ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushima</surname> <given-names>K.</given-names></name> <name><surname>Yang</surname> <given-names>D.</given-names></name> <name><surname>Oppenheim</surname> <given-names>J. J.</given-names></name></person-group> (<year>2022</year>). <article-title>Interleukin-8: An evolving chemokine.</article-title> <source><italic>Cytokine</italic></source> <volume>153</volume>:<fpage>155828</fpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2022.155828</pub-id> <pub-id pub-id-type="pmid">35247648</pub-id></mixed-citation></ref>
<ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirghani</surname> <given-names>R.</given-names></name> <name><surname>Saba</surname> <given-names>T.</given-names></name> <name><surname>Khaliq</surname> <given-names>H.</given-names></name> <name><surname>Mitchell</surname> <given-names>J.</given-names></name> <name><surname>Do</surname> <given-names>L.</given-names></name> <name><surname>Chambi</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Biofilms: Formation, drug resistance and alternatives to conventional approaches.</article-title> <source><italic>AIMS Microbiol.</italic></source> <volume>8</volume> <fpage>239</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.3934/microbiol.2022019</pub-id> <pub-id pub-id-type="pmid">36317001</pub-id></mixed-citation></ref>
<ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname> <given-names>N.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>1996</year>). <article-title>Selective adherence of non-typeable <italic>Haemophilus influenzae</italic> (NTHi) to mucus or epithelial cells in the chinchilla eustachian tube and middle ear.</article-title> <source><italic>Microb Pathog</italic></source> <volume>21</volume> <fpage>343</fpage>&#x2013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1006/mpat.1996.0067</pub-id> <pub-id pub-id-type="pmid">8938642</pub-id></mixed-citation></ref>
<ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokrzan</surname> <given-names>E. M.</given-names></name> <name><surname>Ahearn</surname> <given-names>C. P.</given-names></name> <name><surname>Buzzo</surname> <given-names>J. R.</given-names></name> <name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> newly released (NRel) from biofilms by antibody-mediated dispersal versus antibody-mediated disruption are phenotypically distinct.</article-title> <source><italic>Biofilm</italic></source> <volume>2</volume>:<fpage>100039</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioflm.2020.100039</pub-id> <pub-id pub-id-type="pmid">33447823</pub-id></mixed-citation></ref>
<ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokrzan</surname> <given-names>E. M.</given-names></name> <name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Brockman</surname> <given-names>K. L.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2018</year>). <article-title>Antibodies against the majority subunit (PilA) of the type IV pilus of nontypeable <italic>Haemophilus influenzae</italic> disperse <italic>Moraxella catarrhalis</italic> from a dual-species biofilm.</article-title> <source><italic>mBio</italic></source> <volume>9</volume>:<fpage>e02423-18</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.02423-18</pub-id> <pub-id pub-id-type="pmid">30538189</pub-id></mixed-citation></ref>
<ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>R. K.</given-names></name> <name><surname>Martin</surname> <given-names>A. E.</given-names></name> <name><surname>Zipkowitz</surname> <given-names>S.</given-names></name> <name><surname>Jahan</surname> <given-names>N.</given-names></name> <name><surname>Davis</surname> <given-names>T. D.</given-names></name> <name><surname>Redman</surname> <given-names>W. K.</given-names></name></person-group> (<year>2025</year>). <article-title>alpha-amylase-mediated antibiotic degradation and sequestration in <italic>Pseudomonas aeruginosa</italic> biofilm therapy.</article-title> <source><italic>Antibiotics</italic></source> <volume>14</volume>:<fpage>941</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics14090941</pub-id> <pub-id pub-id-type="pmid">41009919</pub-id></mixed-citation></ref>
<ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2003</year>). <article-title>The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypable <italic>Haemophilus influenzae</italic> is an immunodominant but nonprotective decoying epitope.</article-title> <source><italic>J. Immunol.</italic></source> <volume>171</volume> <fpage>1978</fpage>&#x2013;<lpage>1983</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.171.4.1978</pub-id> <pub-id pub-id-type="pmid">12902501</pub-id></mixed-citation></ref>
<ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Chiang</surname> <given-names>T.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Elmaraghy</surname> <given-names>C. A.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2021</year>). <article-title>Humanized anti-DNABII Fab fragments plus ofloxacin eradicated biofilms in experimental otitis media.</article-title> <source><italic>Laryngoscope</italic></source> <volume>131</volume> <fpage>E2698</fpage>&#x2013;<lpage>E2704</lpage>. <pub-id pub-id-type="doi">10.1002/lary.29497</pub-id> <pub-id pub-id-type="pmid">33666254</pub-id></mixed-citation></ref>
<ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2019</year>). <article-title>Redirecting the immune response towards immunoprotective domains of a DNABII protein resolves experimental otitis media.</article-title> <source><italic>NPJ Vaccines</italic></source> <volume>4</volume>:<fpage>43</fpage>. <pub-id pub-id-type="doi">10.1038/s41541-019-0137-1</pub-id> <pub-id pub-id-type="pmid">31632744</pub-id></mixed-citation></ref>
<ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2020</year>). <article-title>Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections.</article-title> <source><italic>EBioMedicine</italic></source> <volume>59</volume>:<fpage>102867</fpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102867</pub-id> <pub-id pub-id-type="pmid">32651162</pub-id></mixed-citation></ref>
<ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname> <given-names>L. A.</given-names></name> <name><surname>Jurcisek</surname> <given-names>J. A.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo.</article-title> <source><italic>EBioMedicine</italic></source> <volume>10</volume> <fpage>33</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2016.06.022</pub-id> <pub-id pub-id-type="pmid">27342872</pub-id></mixed-citation></ref>
<ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrova</surname> <given-names>O. E.</given-names></name> <name><surname>Sauer</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Escaping the biofilm in more than one way: Desorption, detachment or dispersion.</article-title> <source><italic>Curr. Opin. Microbiol.</italic></source> <volume>30</volume> <fpage>67</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2016.01.004</pub-id> <pub-id pub-id-type="pmid">26826978</pub-id></mixed-citation></ref>
<ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redman</surname> <given-names>W. K.</given-names></name> <name><surname>Welch</surname> <given-names>G. S.</given-names></name> <name><surname>Williams</surname> <given-names>A. C.</given-names></name> <name><surname>Damron</surname> <given-names>A. J.</given-names></name> <name><surname>Northcut</surname> <given-names>W. O.</given-names></name> <name><surname>Rumbaugh</surname> <given-names>K. P.</given-names></name></person-group> (<year>2021</year>). <article-title>Efficacy and safety of biofilm dispersal by glycoside hydrolases in wounds.</article-title> <source><italic>Biofilm</italic></source> <volume>3</volume>:<fpage>100061</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioflm.2021.100061</pub-id> <pub-id pub-id-type="pmid">34825176</pub-id></mixed-citation></ref>
<ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname> <given-names>J. D.</given-names></name> <name><surname>Devaraj</surname> <given-names>A.</given-names></name> <name><surname>Robledo-Avila</surname> <given-names>F.</given-names></name> <name><surname>Balu</surname> <given-names>S.</given-names></name> <name><surname>Mashburn-Warren</surname> <given-names>L.</given-names></name> <name><surname>Buzzo</surname> <given-names>J. R.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Noninflammatory 97-amino acid high mobility group box 1 derived polypeptide disrupts and prevents diverse biofilms.</article-title> <source><italic>EBioMedicine</italic></source> <volume>107</volume>:<fpage>105304</fpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2024.105304</pub-id> <pub-id pub-id-type="pmid">39182358</pub-id></mixed-citation></ref>
<ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname> <given-names>J. V.</given-names></name> <name><surname>Hall</surname> <given-names>V. L.</given-names></name> <name><surname>McOsker</surname> <given-names>C. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Crumbling the castle: Targeting DNABII proteins for collapsing bacterial biofilms as a therapeutic approach to treat disease and combat antimicrobial resistance.</article-title> <source><italic>Antibiotics</italic></source> <volume>11</volume>:<fpage>104</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics11010104</pub-id> <pub-id pub-id-type="pmid">35052981</pub-id></mixed-citation></ref>
<ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roilides</surname> <given-names>E.</given-names></name> <name><surname>Simitsopoulou</surname> <given-names>M.</given-names></name> <name><surname>Katragkou</surname> <given-names>A.</given-names></name> <name><surname>Walsh</surname> <given-names>T. J.</given-names></name></person-group> (<year>2015</year>). <article-title>How biofilms evade host defenses.</article-title> <source><italic>Microbiol. Spectr.</italic></source> <volume>3</volume> <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.MB-0012-2014</pub-id> <pub-id pub-id-type="pmid">26185085</pub-id></mixed-citation></ref>
<ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollet</surname> <given-names>C.</given-names></name> <name><surname>Gal</surname> <given-names>L.</given-names></name> <name><surname>Guzzo</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Biofilm-detached cells, a transition from a sessile to a planktonic phenotype: A comparative study of adhesion and physiological characteristics in <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>FEMS Microbiol. Lett.</italic></source> <volume>290</volume> <fpage>135</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2008.01415.x</pub-id> <pub-id pub-id-type="pmid">19054076</pub-id></mixed-citation></ref>
<ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumbaugh</surname> <given-names>K. P.</given-names></name> <name><surname>Sauer</surname> <given-names>K.</given-names></name></person-group> (<year>2020</year>). <article-title>Biofilm dispersion.</article-title> <source><italic>Nat. Rev. Microbiol.</italic></source> <volume>18</volume> <fpage>571</fpage>&#x2013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-020-0385-0</pub-id> <pub-id pub-id-type="pmid">32533131</pub-id></mixed-citation></ref>
<ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname> <given-names>A.</given-names></name> <name><surname>Jain</surname> <given-names>S.</given-names></name> <name><surname>Junghare</surname> <given-names>M.</given-names></name> <name><surname>Mishra</surname> <given-names>A.</given-names></name> <name><surname>Ruhal</surname> <given-names>R.</given-names></name></person-group> (<year>2025</year>). <article-title>Biofilm-dispersal patterns in ESKAPE pathogens.</article-title> <source><italic>Arch. Microbiol.</italic></source> <volume>207</volume>:<fpage>194</fpage>. <pub-id pub-id-type="doi">10.1007/s00203-025-04394-0</pub-id> <pub-id pub-id-type="pmid">40643714</pub-id></mixed-citation></ref>
<ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>P.</given-names></name> <name><surname>Dlaska</surname> <given-names>C. E.</given-names></name> <name><surname>Perka</surname> <given-names>C.</given-names></name> <name><surname>Trampuz</surname> <given-names>A.</given-names></name> <name><surname>Renz</surname> <given-names>N.</given-names></name></person-group> (<year>2021</year>). <article-title>Preoperative synovial fluid culture poorly predicts the pathogen causing periprosthetic joint infection.</article-title> <source><italic>Infection</italic></source> <volume>49</volume> <fpage>427</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-020-01540-2</pub-id> <pub-id pub-id-type="pmid">33141393</pub-id></mixed-citation></ref>
<ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname> <given-names>L.</given-names></name> <name><surname>Fan</surname> <given-names>H. M.</given-names></name> <name><surname>Tao</surname> <given-names>H. R.</given-names></name> <name><surname>Huang</surname> <given-names>J. D.</given-names></name></person-group> (<year>2022</year>). <article-title>Recent strategies to combat biofilms using antimicrobial agents and therapeutic approaches.</article-title> <source><italic>Pathogens</italic></source> <volume>11</volume>:<fpage>292</fpage>. <pub-id pub-id-type="doi">10.3390/pathogens11030292</pub-id> <pub-id pub-id-type="pmid">35335616</pub-id></mixed-citation></ref>
<ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirakova</surname> <given-names>T.</given-names></name> <name><surname>Kolattukudy</surname> <given-names>P. E.</given-names></name> <name><surname>Murwin</surname> <given-names>D.</given-names></name> <name><surname>Billy</surname> <given-names>J.</given-names></name> <name><surname>Leake</surname> <given-names>E.</given-names></name> <name><surname>Lim</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>1994</year>). <article-title>Role of fimbriae expressed by nontypeable <italic>Haemophilus influenzae</italic> in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A.</article-title> <source><italic>Infect Immun.</italic></source> <volume>62</volume> <fpage>2002</fpage>&#x2013;<lpage>2020</lpage>. <pub-id pub-id-type="doi">10.1128/iai.62.5.2002-2020.1994</pub-id> <pub-id pub-id-type="pmid">7909539</pub-id></mixed-citation></ref>
<ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spratt</surname> <given-names>M. R.</given-names></name> <name><surname>Lane</surname> <given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>Navigating environmental transitions: The role of phenotypic variation in bacterial responses.</article-title> <source><italic>mBio</italic></source> <volume>13</volume>:<fpage>e0221222</fpage>. <pub-id pub-id-type="doi">10.1128/mbio.02212-22</pub-id> <pub-id pub-id-type="pmid">36259726</pub-id></mixed-citation></ref>
<ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swinger</surname> <given-names>K. K.</given-names></name> <name><surname>Rice</surname> <given-names>P. A.</given-names></name></person-group> (<year>2004</year>). <article-title>IHF and HU: Flexible architects of bent DNA.</article-title> <source><italic>Curr. Opin. Struct. Biol.</italic></source> <volume>14</volume> <fpage>28</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2003.12.003</pub-id> <pub-id pub-id-type="pmid">15102446</pub-id></mixed-citation></ref>
<ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uppuluri</surname> <given-names>P.</given-names></name> <name><surname>Acosta Zaldivar</surname> <given-names>M.</given-names></name> <name><surname>Anderson</surname> <given-names>M. Z.</given-names></name> <name><surname>Dunn</surname> <given-names>M. J.</given-names></name> <name><surname>Berman</surname> <given-names>J.</given-names></name> <name><surname>Lopez Ribot</surname> <given-names>J. L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title><italic>Candida albicans</italic> dispersed cells are developmentally distinct from biofilm and planktonic cells.</article-title> <source><italic>mBio</italic></source> <volume>9</volume>:<fpage>e01338-18</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.01338-18</pub-id> <pub-id pub-id-type="pmid">30131358</pub-id></mixed-citation></ref>
<ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uru&#x00E9;n</surname> <given-names>C.</given-names></name> <name><surname>Chopo-Escuin</surname> <given-names>G.</given-names></name> <name><surname>Tommassen</surname> <given-names>J.</given-names></name> <name><surname>Mainar-Jaime</surname> <given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>Biofilms as promoters of bacterial antibiotic resistance and tolerance.</article-title> <source><italic>Antibiotics</italic></source> <volume>10</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics10010003</pub-id> <pub-id pub-id-type="pmid">33374551</pub-id></mixed-citation></ref>
<ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbanks</surname> <given-names>K. Q.</given-names></name> <name><surname>Mokrzan</surname> <given-names>E. M.</given-names></name> <name><surname>Kesler</surname> <given-names>T. M.</given-names></name> <name><surname>Kurbatfinski</surname> <given-names>N.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Bakaletz</surname> <given-names>L. O.</given-names></name></person-group> (<year>2023</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> released from biofilm residence by monoclonal antibody directed against a biofilm matrix component display a vulnerable phenotype.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>13</volume>:<fpage>12959</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-023-40284-5</pub-id> <pub-id pub-id-type="pmid">37563215</pub-id></mixed-citation></ref>
<ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Cang</surname> <given-names>W.</given-names></name> <name><surname>Mu</surname> <given-names>D.</given-names></name> <name><surname>Ji</surname> <given-names>S.</given-names></name> <name><surname>An</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Biofilm tolerance, resistance and infections increasing threat of public health.</article-title> <source><italic>Microb Cell</italic></source> <volume>10</volume> <fpage>233</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.15698/mic2023.11.807</pub-id> <pub-id pub-id-type="pmid">37933277</pub-id></mixed-citation></ref>
<ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zemke</surname> <given-names>A. C.</given-names></name> <name><surname>D&#x2019;Amico</surname> <given-names>E. J.</given-names></name> <name><surname>Snell</surname> <given-names>E. C.</given-names></name> <name><surname>Torres</surname> <given-names>A. M.</given-names></name> <name><surname>Kasturiarachi</surname> <given-names>N.</given-names></name> <name><surname>Bomberger</surname> <given-names>J. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Dispersal of epithelium-associated <italic>Pseudomonas aeruginosa</italic> biofilms.</article-title> <source><italic>mSphere</italic></source> <volume>5</volume>:<fpage>e00630-20</fpage>. <pub-id pub-id-type="doi">10.1128/mSphere.00630-20</pub-id> <pub-id pub-id-type="pmid">32669459</pub-id></mixed-citation></ref>
<ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>A.</given-names></name> <name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Understanding bacterial biofilms: From definition to treatment strategies.</article-title> <source><italic>Front. Cell Infect. Microbiol.</italic></source> <volume>13</volume>:<fpage>1137947</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2023.1137947</pub-id> <pub-id pub-id-type="pmid">37091673</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/326638/overview">Enea Gino Di Domenico</ext-link>, San Gallicano Dermatological Institute IRCCS, Italy</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/238032/overview">Stephen Glen Tristram</ext-link>, University of Tasmania, Australia</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2772761/overview">Brianna Atto</ext-link>, University of Tasmania, Australia</p></fn>
</fn-group>
</back>
</article>